Oklahoma 2022 Regular Session

Oklahoma House Bill HB3439 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1		-	An Act
2		-	ENROLLED HOUSE
	1	+
	2	+
	3	+	ENGR. S. A. TO ENGR. H. B. NO. 3439 Page 1 1
	4	+	2
	5	+	3
	6	+	4
	7	+	5
	8	+	6
	9	+	7
	10	+	8
	11	+	9
	12	+	10
	13	+	11
	14	+	12
	15	+	13
	16	+	14
	17	+	15
	18	+	16
	19	+	17
	20	+	18
	21	+	19
	22	+	20
	23	+	21
	24	+	22
	25	+	23
	26	+	24
	27	+
	28	+	ENGROSSED SENATE AMENDMENT
	29	+	TO
	30	+	ENGROSSED HOUSE
3	31		BILL NO. 3439 By: Kerbs of the House
4	32
5	33		and
6	34
7	35		Kidd of the Senate
8	36
9	37
10	38
11	39
12		-
13		-
14		-	An Act relating to industrial hemp; amending 2 O.S.
	40	+	[ industrial hemp – Oklahoma Industrial Hemp Program
	41	+	- providing that the Oklahoma Conservation
	42	+	Commission shall have jurisdiction over the
	43	+	creation and verification of carbon credits from
	44	+	the Oklahoma Industrial Hemp Program –
	45	+	emergency ]
	46	+
	47	+
	48	+
	49	+
	50	+	AMENDMENT NO. 1. Page 1, strike the stricken title, enacting clause
	51	+	and entire bill and insert
	52	+
	53	+
	54	+	"An Act relating to industrial hemp; amending 2 O.S.
15	55		2021, Sections 3-402, 3-403, and 3-408, which relate
16	56		to the Oklahoma Industrial Hemp Program; modifying
17	57		definitions; allowing licensee to remediate
18	58		noncompliant industrial hemp; providing guidelines
19	59		for location of remediation testing and time frame;
20	60		providing that licensee may sell industrial hemp
21	61		grain and other industrial hemp derivatives ;
22	62		providing that for certain delta -9
23	63		tetrahydrocannabinol concentration testing levels the
24	64		licensee shall not be subject to any penalty if the
25	65		crop is destroyed or reme diated; amending 63 O.S.
26		-	2021, Section 2-101, as amended by Section 1, Chapter
27		-	222, O.S.L. 2021, which relates to the Uniform
28		-	Controlled Dangerous Substances Act; modifying the
29		-	definition of tetrahydrocannabinols to include
30		-	industrial hemp; and declar ing an emergency.
31		-
32		-
33		-
34		-
35		-	SUBJECT: Industrial hemp
	66	+	2021, Section 2-101, as last amended by Section 1,
	67	+	Chapter 222, O.S.L. 2021, which relates to the
	68	+	Uniform Controlled Dangerous Substances Act;
	69	+
	70	+	ENGR. S. A. TO ENGR. H. B. NO. 3439 Page 2 1
	71	+	2
	72	+	3
	73	+	4
	74	+	5
	75	+	6
	76	+	7
	77	+	8
	78	+	9
	79	+	10
	80	+	11
	81	+	12
	82	+	13
	83	+	14
	84	+	15
	85	+	16
	86	+	17
	87	+	18
	88	+	19
	89	+	20
	90	+	21
	91	+	22
	92	+	23
	93	+	24
	94	+
	95	+	modifying the definition of tetrahydrocannabinols to
	96	+	include industrial hemp; and declar ing an emergency.
	97	+
	98	+
	99	+
36	100
37	101		BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
38		-
39	102		SECTION 1. AMENDATORY 2 O.S. 2021, Section 3 -402, is
40	103		amended to read as follows:
41		-
42	104		Section 3-402. As used in the Oklahom a Industrial Hemp Program:
43		-
44		-	1. "Department" means the Oklahoma Department of Agriculture,
	105	+	1. “Department” means the Oklahoma Department of Agriculture,
45	106		Food, and Forestry;
46		-	ENR. H. B. NO. 3439 Page 2
47		-	2. "Fiber" means the stalk of the industrial hemp plant and
	107	+	2. “Fiber” means the stalk of the industrial hemp plant and
48	108		does not include the flower or seeds of the plant;
49		-
50		-	3. "Flower" means the part of the industrial hemp plant that
51		-	contains the majority of the industrial hemp plant's
	109	+	3. “Flower” means the part of the industrial hemp plant that
	110	+	contains the majority of the industrial hemp plant’s
52	111		tetrahydrocannabinol and other cannabinoids ;
53		-
54		-	4. "Grain" means all of the parts of an industrial hemp plant
	112	+	4. “Grain” means all of the parts of an industrial hemp plant
55	113		except the stalk or the flower of the industrial hemp plant;
56		-
57		-	5. "Handling" means possessing or storing industrial hemp for
	114	+	5. “Handling” means possessing or storing industrial hemp for
58	115		any period of time on premises owned, operated or controlled by a
59	116		person licensed to cultivate or process industrial hemp and al so
60	117		includes possessing or storing industrial he mp in a vehicle for any
61	118		period of time other than during its actual transport from the
62	119		premises of a licensed person to cultivate or process industri al
63	120		hemp to the premises of another licensed person;
64	121
65		-	3. 6. "Industrial hemp" means the plant Cannabis sativ a L. and
	122	+	ENGR. S. A. TO ENGR. H. B. NO. 3439 Page 3 1
	123	+	2
	124	+	3
	125	+	4
	126	+	5
	127	+	6
	128	+	7
	129	+	8
	130	+	9
	131	+	10
	132	+	11
	133	+	12
	134	+	13
	135	+	14
	136	+	15
	137	+	16
	138	+	17
	139	+	18
	140	+	19
	141	+	20
	142	+	21
	143	+	22
	144	+	23
	145	+	24
	146	+
	147	+	3. 6. “Industrial hemp” means the plant Cannabis sativ a L. and
66	148		any part of the plant, including the seeds thereof, and all
67	149		derivatives, extracts, cannabinoids, isomers, acids, salts and salts
68	150		of isomers, whether growing or not, with a delta -9
69	151		tetrahydrocannabinol concentration of not more than three -tenths of
70	152		one percent (0.3%) on a dry-weight basis;
71		-
72		-	4. 7. "Licensee" means a person who holds a valid Industrial
	153	+	4. 7. “Licensee” means a person who holds a valid Industrial
73	154		Hemp License to grow industrial hemp under t he Oklahoma Industrial
74	155		Hemp Program. A licensee shall have the ability to remediate
75	156		noncompliant industrial hemp with a delta-9 tetrahydrocannabinol
76	157		concentration of not more than one percent (1.0%) on a dry-weight
77	158		basis for retesting as set forth by the Department as long as the
78	159		noncompliant industrial hemp has a delta-9 tetrahydrocannabinol
79	160		concentration of not more than three-tenths of one percent (0.3%) on
80	161		a dry-weight basis after retesting, and the option to remediate the
81	162		industrial hemp through the reasonable destruction of the flower or
82	163		shredding of the entire lot into a homogeneous biomass results in
83	164		the remediation of any par t of the industrial hemp plant that is
84	165		above three-tenths of one percent (0.3%) on a dry-weight basis. All
85	166		noncompliant hemp must be tracked and documented. The State Board
86	167		of Agriculture shall have jurisdiction over such remediation, which
87	168		includes, but is not limited to, destruction through composting,
88	169		burning, or other regulated disposal methods if the industrial hemp
	170	+
	171	+	ENGR. S. A. TO ENGR. H. B. NO. 3439 Page 4 1
	172	+	2
	173	+	3
	174	+	4
	175	+	5
	176	+	6
	177	+	7
	178	+	8
	179	+	9
	180	+	10
	181	+	11
	182	+	12
	183	+	13
	184	+	14
	185	+	15
	186	+	16
	187	+	17
	188	+	18
	189	+	19
	190	+	20
	191	+	21
	192	+	22
	193	+	23
	194	+	24
	195	+
89	196		is not remediated into a final product before processing below
90	197		three-tenths of one percent (0.3%) on a dry -weight basis;
91		-	ENR. H. B. NO. 3439 Page 3
92		-	5. 8. "License" means authorization by the Department for any
	198	+	5. 8. “License” means authorization by the Department for any
93	199		person to grow and cultivate industrial hemp on a registered land
94	200		area as part of the Oklahoma Industrial Hemp Program; and
95		-
96		-	6. 9. "Processing" means converting industrial hemp into a
	201	+	6. 9. “Processing” means converting industrial hemp into a
97	202		marketable form, including the production of all derivatives,
98	203		extracts, cannabinoids, isomers, acids, salts and salts of isomers.
99		-
100	204		SECTION 2. AMENDATORY 2 O.S. 2021, Section 3 -403, is
101	205		amended to read as follows:
102		-
103	206		Section 3-403. A. 1. A licensee is authorized to engage in
104	207		the growth, cultivation, handling or processing of industrial hemp
105	208		and may remediate noncompliant industrial hemp with a delta-9
106	209		tetrahydrocannabinol concentration of not mo re than one percent
107	210		(1.0%) on a dry-weight basis and prepare for retesting as set forth
108	211		by the Department as long as the noncompliant industrial hemp has a
109	212		delta-9 tetrahydrocannabinol conc entration of not more than three -
110	213		tenths of one percent (0.3%) on a dry-weight basis after re testing,
111	214		or all or part of the product is disposed of in the process of
112	215		remediation so that only a compliant product (with a delta-9
113	216		tetrahydrocannabinol concentrat ion of not more than three -tenths of
114	217		one percent (0.3%) on a dry -weight basis) is left, or all disposable
115	218		waste is destroyed follow ing a remediation process.
	219	+
	220	+	ENGR. S. A. TO ENGR. H. B. NO. 3439 Page 5 1
	221	+	2
	222	+	3
	223	+	4
	224	+	5
	225	+	6
	226	+	7
	227	+	8
	228	+	9
	229	+	10
	230	+	11
	231	+	12
	232	+	13
	233	+	14
	234	+	15
	235	+	16
	236	+	17
	237	+	18
	238	+	19
	239	+	20
	240	+	21
	241	+	22
	242	+	23
	243	+	24
116	244
117	245		2. A remediation facility shall be an option of the remediation
118	246		process. The licensee may remediate any noncompliant industrial
119	247		hemp at its own facilities, affiliated facilities, or third -party
120	248		facilities as long as these facil ities are licensed and approved by
121	249		the State Board of Agriculture as a remediation facility. The State
122	250		Board of Agriculture shall be notified before any non compliant
123	251		industrial hemp is transported to a remediation facility. Retesting
124	252		of any noncompliant industrial hemp shall be done within sixty (60)
125	253		days post-harvest. Within seven (7) days of receiving notice of a
126	254		measured tetrahydrocannabinol concentration that exceeds the
127	255		acceptable hemp tetrahydrocannabinol level but is less than one
128	256		percent (1.0%), the licensed grower shall consent to the destruction
129	257		of all cannabis from that lot, or he or she may request remediation
130	258		and a post-harvest retest in a homogenized form in accordance with
131	259		the procedures established by the State Board of Agriculture. A
132	260		measured tetrahydrocannabinol concentration that exceeds one percent
133	261		(1.0%) shall require the licensed grower to properly dispose of all
134	262		cannabis from that lot. The retest fee shall be paid in an amount
135	263		established by the State Board of Agriculture. Samples with a
136		-	measured tetrahydrocannabinol concentration of one percent (1.0%) or ~~ENR. H. B. NO. 3439 Page 4~~
	264	+	measured tetrahydrocannabinol concentration of one percent (1.0%) or
137	265		greater shall not be eligible for a post -harvest retest or
138	266		remediation and shall be destroye d.
139		-
140	267		3. Licensees are allowed to sell industrial hemp grain and
141	268		other industrial hemp derivatives that are either grown or processed
	269	+
	270	+	ENGR. S. A. TO ENGR. H. B. NO. 3439 Page 6 1
	271	+	2
	272	+	3
	273	+	4
	274	+	5
	275	+	6
	276	+	7
	277	+	8
	278	+	9
	279	+	10
	280	+	11
	281	+	12
	282	+	13
	283	+	14
	284	+	15
	285	+	16
	286	+	17
	287	+	18
	288	+	19
	289	+	20
	290	+	21
	291	+	22
	292	+	23
	293	+	24
	294	+
142	295		in this state, that do not include the flower, for the purpose of
143	296		livestock feed and other animal consumption in this state.
144		-
145	297		B. The activities performed under the Oklahoma Industrial Hemp
146	298		Program shall not subject the persons participating in the program
147	299		to criminal liability under the Uniform Controlled Dangerous
148	300		Substances Act. The exemption from criminal liability pr ovided for
149	301		in this subsection is a limited exemption that shall be strictly
150	302		construed and shall not apply to an activity that is not expressly
151	303		permitted under the Okl ahoma Industrial Hemp Program.
152		-
153	304		SECTION 3. AMENDATORY 2 O.S. 2021 , Section 3-408, is
154	305		amended to read as follows:
155		-
156	306		Section 3-408. A. The Department may deny, revoke or suspend a
157	307		license if the licensee:
158		-
159	308		1. Violates any provision of the Oklahoma Industrial Hemp
160	309		Program or rules adop ted pursuant to the program;
161		-
162	310		2. Engages in fraud or deception in the procurement of or
163	311		attempt to procure a license under this the Oklahoma Industrial Hemp
164	312		Program or provides false information on a license application;
165		-
166	313		3. Refuses or fails to cooperate a nd assist the Department with
167	314		the inspection process;
168		-
169	315		4. Refuses or fails to provide any information required or
170	316		requested by the Department for purposes of the Oklahoma Industrial
171	317		Hemp Program;
172	318
	319	+	ENGR. S. A. TO ENGR. H. B. NO. 3439 Page 7 1
	320	+	2
	321	+	3
	322	+	4
	323	+	5
	324	+	6
	325	+	7
	326	+	8
	327	+	9
	328	+	10
	329	+	11
	330	+	12
	331	+	13
	332	+	14
	333	+	15
	334	+	16
	335	+	17
	336	+	18
	337	+	19
	338	+	20
	339	+	21
	340	+	22
	341	+	23
	342	+	24
	343	+
	344	+	5. Knowingly provides false, misleading or incorrect
	345	+	information pertaining to the licensee’s cultivation, handling or
	346	+	processing of industrial hemp to the Department by any means,
	347	+	including information provided in any application form, report,
	348	+	record or inspection required or maintained for purposes of the
	349	+	Oklahoma Industrial Hemp Program;
	350	+	6. Fails to submit any report required by the Oklahoma
	351	+	Industrial Hemp Program; or
	352	+	7. Fails to pay fees required by the Oklahoma Industrial Hemp
	353	+	Program.
	354	+	B. 1. A licensee that negligently violates the provisions of
	355	+	the Oklahoma Industrial Hemp Program shall not be subject to a
	356	+	criminal enforcement action If a sample of a licensee’s industrial
	357	+	hemp tests higher than three-tenths of one percent (0.3%) but less
	358	+	than one percent (1.0%) on a dry-weight basis for delta-9
	359	+	tetrahydrocannabinol concentration, the licensee shall not be
	360	+	subject to any penalty under the Oklahoma Industrial Hemp Program if
	361	+	the crop is destroyed or remediated.
	362	+	2. A licensee that negligently violates the prov isions of the
	363	+	Oklahoma Industrial Hemp Program th ree times in any five-year period
	364	+	shall be ineligible to obtain a license pursuant to the Oklahoma
	365	+	Industrial Hemp Program for a period of five (5) years beginning on
	366	+	the date of the third violation.
	367	+
	368	+	ENGR. S. A. TO ENGR. H. B. NO. 3439 Page 8 1
	369	+	2
	370	+	3
	371	+	4
	372	+	5
	373	+	6
	374	+	7
	375	+	8
	376	+	9
	377	+	10
	378	+	11
	379	+	12
	380	+	13
	381	+	14
	382	+	15
	383	+	16
	384	+	17
	385	+	18
	386	+	19
	387	+	20
	388	+	21
	389	+	22
	390	+	23
	391	+	24
	392	+
	393	+	C. Any person convicted of a felony relating to a contr olled
	394	+	substance under state or federal law shall be ineligible during the
	395	+	ten-year period following the date of conviction to participate in
	396	+	this program.
	397	+	SECTION 4. AMENDATORY 63 O.S. 2021, Section 2-101, as
	398	+	last amended by Secti on 1, Chapter 222, O.S.L. 2021, is amended to
	399	+	read as follows:
	400	+	Section 2-101. As used in the Uniform Controlled Dangerous
	401	+	Substances Act:
	402	+	1. “Administer” means the direct application of a controlled
	403	+	dangerous substance, whether by injection, inhalation, ingestion or
	404	+	any other means, to the body of a patient, animal or rese arch
	405	+	subject by:
	406	+	a. a practitioner (or, in the presence of the
	407	+	practitioner, by the authorized agent of the
	408	+	practitioner), or
	409	+	b. the patient or research subject at the direction and
	410	+	in the presence of the practitioner;
	411	+	2. “Agent” means a peace officer app ointed by and who acts o n
	412	+	behalf of the Director of the Oklahoma State Bureau of Narcotics and
	413	+	Dangerous Drugs Control or an authorized p erson who acts on behalf
	414	+	of or at the direction of a person who manufactures, distrib utes,
	415	+	dispenses, prescribes, admin isters or uses for scien tific purposes
	416	+	controlled dangerous substances but does not include a common or
	417	+
	418	+	ENGR. S. A. TO ENGR. H. B. NO. 3439 Page 9 1
	419	+	2
	420	+	3
	421	+	4
	422	+	5
	423	+	6
	424	+	7
	425	+	8
	426	+	9
	427	+	10
	428	+	11
	429	+	12
	430	+	13
	431	+	14
	432	+	15
	433	+	16
	434	+	17
	435	+	18
	436	+	19
	437	+	20
	438	+	21
	439	+	22
	440	+	23
	441	+	24
	442	+
	443	+	contract carrier, public warehous er or employee thereof, or a person
	444	+	required to register under the Uniform Controlled Dangerous
	445	+	Substances Act;
	446	+	3. “Board” means the Advisory Board to the Director of the
	447	+	Oklahoma State Bureau of Narcotics and Dangerous Drugs Control;
	448	+	4. “Bureau” means the Oklahoma State Bureau of Narcotics and
	449	+	Dangerous Drugs Control;
	450	+	5. “Coca leaves” includes cocaine and any compound,
	451	+	manufacture, salt, deri vative, mixture or preparation of coca
	452	+	leaves, except derivatives of coca leaves which do not contain
	453	+	cocaine or ecgonine;
	454	+	6. “Commissioner” or “Director” means the Director of the
	455	+	Oklahoma State Bureau of Narcotics and Dangerous D rugs Control;
	456	+	7. “Control” means to add, remove or change the placement of a
	457	+	drug, substance or immediate precursor under the Uniform Co ntrolled
	458	+	Dangerous Substances Act;
	459	+	8. “Controlled dangerous substance ” means a drug, substance or
	460	+	immediate precursor in Schedules I through V of the Uniform
	461	+	Controlled Dangerous Substances Act or any drug, substance or
	462	+	immediate precursor listed either t emporarily or permanently as a
	463	+	federally controlled substance. Any conflict between state and
	464	+	federal law with regard to the particular schedu le in which a
	465	+	substance is listed shall be resolved in favor of state law;
	466	+
	467	+	ENGR. S. A. TO ENGR. H. B. NO. 3439 Page 10 1
	468	+	2
	469	+	3
	470	+	4
	471	+	5
	472	+	6
	473	+	7
	474	+	8
	475	+	9
	476	+	10
	477	+	11
	478	+	12
	479	+	13
	480	+	14
	481	+	15
	482	+	16
	483	+	17
	484	+	18
	485	+	19
	486	+	20
	487	+	21
	488	+	22
	489	+	23
	490	+	24
	491	+
	492	+	9. “Counterfeit substance” means a controlled substance which,
	493	+	or the container or labeling of which without authorization , bears
	494	+	the trademark, trade name or other identifying mar ks, imprint,
	495	+	number or device or any likeness thereof of a manufacturer,
	496	+	distributor or dispenser other than the person who in fact
	497	+	manufactured, distributed or dispensed the substance;
	498	+	10. “Deliver” or “delivery” means the actual, constructive or
	499	+	attempted transfer from one person to another of a controlled
	500	+	dangerous substance or drug paraphernalia, whether or not there is
	501	+	an agency relationship;
	502	+	11. “Dispense” means to deliver a controlled danger ous
	503	+	substance to an ultimate user or human research subjec t by or
	504	+	pursuant to the lawful order of a practitioner, including the
	505	+	prescribing, administering, packaging, labe ling or compounding
	506	+	necessary to prepare the substance for such distribution.
	507	+	“Dispenser” is a practitioner who delive rs a controlled dangerou s
	508	+	substance to an ultimate user or human research subject;
	509	+	12. “Distribute” means to deliver other than by admin istering
	510	+	or dispensing a controlled dangerous substance;
	511	+	13. “Distributor” means a commercial entity engaged in the
	512	+	distribution or reverse di stribution of narcotics and dangerous
	513	+	drugs and who complies with all regulations promulgated by the
	514	+	federal Drug Enforcement Administration and the Oklahoma State
	515	+	Bureau of Narcotics and Dangerous Drugs Control;
	516	+
	517	+	ENGR. S. A. TO ENGR. H. B. NO. 3439 Page 11 1
	518	+	2
	519	+	3
	520	+	4
	521	+	5
	522	+	6
	523	+	7
	524	+	8
	525	+	9
	526	+	10
	527	+	11
	528	+	12
	529	+	13
	530	+	14
	531	+	15
	532	+	16
	533	+	17
	534	+	18
	535	+	19
	536	+	20
	537	+	21
	538	+	22
	539	+	23
	540	+	24
	541	+
	542	+	14. “Drug” means articles:
	543	+	a. recognized in the official United States Pharmacopeia,
	544	+	official Homeopathic Pharmacopoeia of the United
	545	+	States, or official N ational Formulary, or any
	546	+	supplement to any of them,
	547	+	b. intended for use in the diagn osis, cure, mitigation,
	548	+	treatment or prevention of disease in man or other
	549	+	animals,
	550	+	c. other than food, intended to affect the structure or
	551	+	any function of the body of man or other animals, and
	552	+	d. intended for use as a component of any article
	553	+	specified in this paragraph;
	554	+	provided, however, the term “drug” does not include devices or their
	555	+	components, parts or accessories;
	556	+	15. “Drug-dependent person” means a person who is using a
	557	+	controlled dangerous substance and who is in a state of psychic or
	558	+	physical dependence, or both, arising from a dministration of that
	559	+	controlled dangerous substance on a continuous basis. Drug
	560	+	dependence is characterized by behavioral and other res ponses which
	561	+	include a strong compulsion to take the substance on a continuous
	562	+	basis in order to experience its psychic effects, or to avoid th e
	563	+	discomfort of its absence;
	564	+	16. “Home care agency” means any sole proprietorship,
	565	+	partnership, association, cor poration, or other organization which
	566	+
	567	+	ENGR. S. A. TO ENGR. H. B. NO. 3439 Page 12 1
	568	+	2
	569	+	3
	570	+	4
	571	+	5
	572	+	6
	573	+	7
	574	+	8
	575	+	9
	576	+	10
	577	+	11
	578	+	12
	579	+	13
	580	+	14
	581	+	15
	582	+	16
	583	+	17
	584	+	18
	585	+	19
	586	+	20
	587	+	21
	588	+	22
	589	+	23
	590	+	24
	591	+
	592	+	administers, offers, or provides home care serv ices, for a fee or
	593	+	pursuant to a contract for such service s, to clients in their place
	594	+	of residence;
	595	+	17. “Home care services” means skilled or personal care
	596	+	services provided to clients in their place of residence for a fee;
	597	+	18. “Hospice” means a centrally administered, nonprofit or for -
	598	+	profit, medically direct ed, nurse-coordinated program which provides
	599	+	a continuum of home and inpatient care for the terminally ill
	600	+	patient and the patient’s family. Such term shall also include a
	601	+	centrally administered, n onprofit or for-profit, medically directed,
	602	+	nurse-coordinated program if such program is licensed pursuant to
	603	+	the provisions of the Uniform Controlled Dangerous Substances Act.
	604	+	A hospice program offers palliative and supportive care to meet the
	605	+	special needs arising out of the physical, e motional and spiritual
	606	+	stresses which are experienced during the final stages of illness
	607	+	and during dying and bereavement. This care is available twenty-
	608	+	four (24) hours a day, seven (7) days a week, and is provided on the
	609	+	basis of need, regardless of abil ity to pay. “Class A” Hospice
	610	+	refers to Medicare-certified hospices. “Class B” refers to all
	611	+	other providers of hospice services;
	612	+	19. “Imitation controlled substance” means a substance that is
	613	+	not a controlled dangerous substance, which by dosage unit
	614	+	appearance, color, shape, size, markings or by representations made,
	615	+	would lead a reasonable person to believe that the substance is a
	616	+
	617	+	ENGR. S. A. TO ENGR. H. B. NO. 3439 Page 13 1
	618	+	2
	619	+	3
	620	+	4
	621	+	5
	622	+	6
	623	+	7
	624	+	8
	625	+	9
	626	+	10
	627	+	11
	628	+	12
	629	+	13
	630	+	14
	631	+	15
	632	+	16
	633	+	17
	634	+	18
	635	+	19
	636	+	20
	637	+	21
	638	+	22
	639	+	23
	640	+	24
	641	+
	642	+	controlled dangerous substance. In the event the appearance of the
	643	+	dosage unit is not r easonably sufficient to establish that the
	644	+	substance is an “imitation controlled substance”, the court or
	645	+	authority concerned should consider, in addition to all other
	646	+	factors, the following factors as related to “representations made”
	647	+	in determining wheth er the substance is an “imitation controlled
	648	+	substance”:
	649	+	a. statements made by an owner or by any other person in
	650	+	control of the substance concerning the nature of the
	651	+	substance, or its use or effect,
	652	+	b. statements made to the recipient that the substance
	653	+	may be resold for inordinate profi t,
	654	+	c. whether the substance is packaged in a manner normally
	655	+	used for illicit controlled substances,
	656	+	d. evasive tactics or actions utiliz ed by the owner or
	657	+	person in control of the substance to avoid detection
	658	+	by law enforcement authorities,
	659	+	e. prior convictions, if any, of an ow ner, or any other
	660	+	person in control of the object, under state or
	661	+	federal law related to controlled substances or fraud,
	662	+	and
	663	+	f. the proximity of the substances to controlled
	664	+	dangerous substances;
	665	+
	666	+	ENGR. S. A. TO ENGR. H. B. NO. 3439 Page 14 1
	667	+	2
	668	+	3
	669	+	4
	670	+	5
	671	+	6
	672	+	7
	673	+	8
	674	+	9
	675	+	10
	676	+	11
	677	+	12
	678	+	13
	679	+	14
	680	+	15
	681	+	16
	682	+	17
	683	+	18
	684	+	19
	685	+	20
	686	+	21
	687	+	22
	688	+	23
	689	+	24
	690	+
	691	+	20. “Immediate precursor” means a substance which the Direc tor
	692	+	has found to be and by regulation designates as being the principal
	693	+	compound commonly used or produced primar ily for use, and which is
	694	+	an immediate chemical intermediary used, or likely to be us ed, in
	695	+	the manufacture of a contro lled dangerous substance , the control of
	696	+	which is necessary to prevent, curtail or limit such manufacture;
	697	+	21. “Laboratory” means a laboratory approved by the Director as
	698	+	proper to be entrusted with the custody of control led dangerous
	699	+	substances and the u se of controlled dangero us substances for
	700	+	scientific and medical purposes and for purposes of instruction;
	701	+	22. “Manufacture” means the production, preparation,
	702	+	propagation, compounding or processing of a controlled danger ous
	703	+	substance, either directly or indirectly by extraction from
	704	+	substances of natural or synthetic origin, or independently by means
	705	+	of chemical synthesis or by a combinat ion of extraction and chemical
	706	+	synthesis. “Manufacturer” includes any person who pac kages,
	707	+	repackages or labels any co ntainer of any controlle d dangerous
	708	+	substance, except practitioners who dispense or compound
	709	+	prescription orders for delivery to the ulti mate consumer;
	710	+	23. “Marijuana” means all parts of the plant Cannabis sativa
	711	+	L., whether growing or not; the seeds ther eof; the resin extracted
	712	+	from any part of such plant; and every compound, manufacture, salt,
	713	+	derivative, mixture or preparation of such p lant, its seeds or
	714	+	resin, but shall not include:
	715	+
	716	+	ENGR. S. A. TO ENGR. H. B. NO. 3439 Page 15 1
	717	+	2
	718	+	3
	719	+	4
	720	+	5
	721	+	6
	722	+	7
	723	+	8
	724	+	9
	725	+	10
	726	+	11
	727	+	12
	728	+	13
	729	+	14
	730	+	15
	731	+	16
	732	+	17
	733	+	18
	734	+	19
	735	+	20
	736	+	21
	737	+	22
	738	+	23
	739	+	24
	740	+
	741	+	a. the mature stalks of such plant o r fiber produced from
	742	+	such stalks,
	743	+	b. oil or cake made fro m the seeds of such plant,
	744	+	including cannabidiol derived from the seeds of the
	745	+	marijuana plant,
	746	+	c. any other compound, manufacture, salt, derivative,
	747	+	mixture or preparation of such mature stalks (ex cept
	748	+	the resin extracted therefrom ), including cannabidiol
	749	+	derived from mature stalks, fiber, oil or cake,
	750	+	d. the sterilized seed of such plant which is incapable
	751	+	of germination,
	752	+	e. for any person participating in a clinical trial to
	753	+	administer cannabidiol for the treatment of severe
	754	+	forms of epilepsy pursuant to Section 2-802 of this
	755	+	title, a drug or substance approved by the federal
	756	+	Food and Drug Administration for use by those
	757	+	participants,
	758	+	f. for any person or the parents, legal guardians or
	759	+	caretakers of the person who have received a written
	760	+	certification from a physician licensed in this state
	761	+	that the person has been diagnosed by a physician as
	762	+	having Lennox-Gastaut syndrome, Dravet syndrome, also
	763	+	known as severe myoclonic epilepsy of infancy, or any
	764	+	other severe form of epilepsy tha t is not adequately
	765	+
	766	+	ENGR. S. A. TO ENGR. H. B. NO. 3439 Page 16 1
	767	+	2
	768	+	3
	769	+	4
	770	+	5
	771	+	6
	772	+	7
	773	+	8
	774	+	9
	775	+	10
	776	+	11
	777	+	12
	778	+	13
	779	+	14
	780	+	15
	781	+	16
	782	+	17
	783	+	18
	784	+	19
	785	+	20
	786	+	21
	787	+	22
	788	+	23
	789	+	24
	790	+
	791	+	treated by traditional medical therapies, spasticity
	792	+	due to multiple sclerosis or due to paraplegia,
	793	+	intractable nausea and vomiting, appetite stimulation
	794	+	with chronic wasting diseases, the substance
	795	+	cannabidiol, a nonpsychoactive canna binoid, found in
	796	+	the plant Cannabis sativa L. or any other preparation
	797	+	thereof, that has a tetrahydrocannabinol concentration
	798	+	of not more than three-tenths of one percent (0.3%)
	799	+	and that is delivered to the patient in the form of a
	800	+	liquid,
	801	+	g. any federal Food-and-Drug-Administration-approved drug
	802	+	or substance, or
	803	+	h. industrial hemp, from the plant Cannabis sativa L. and
	804	+	any part of such pla nt, whether growing or not, with a
	805	+	delta-9 tetrahydrocannabinol concentration of not more
	806	+	than three-tenths of one percent (0.3%) on a dry
	807	+	weight dry-weight basis which shall only be grown
	808	+	pursuant to the Oklahoma Industrial Hemp Program and
	809	+	may be shipped intrastate and interstate;
	810	+	24. “Medical purpose” means an intention to utilize a
	811	+	controlled dangerous substance for physical or mental treatment, for
	812	+	diagnosis, or for the prevention of a disease condition not in
	813	+	violation of any state or federal law and not for the purpose of
	814	+	satisfying physiological or psychological dependence or other abuse;
	815	+
	816	+	ENGR. S. A. TO ENGR. H. B. NO. 3439 Page 17 1
	817	+	2
	818	+	3
	819	+	4
	820	+	5
	821	+	6
	822	+	7
	823	+	8
	824	+	9
	825	+	10
	826	+	11
	827	+	12
	828	+	13
	829	+	14
	830	+	15
	831	+	16
	832	+	17
	833	+	18
	834	+	19
	835	+	20
	836	+	21
	837	+	22
	838	+	23
	839	+	24
	840	+
	841	+	25. “Mid-level practitioner” means an Advanced Practice
	842	+	Registered Nurse as defined and within parameters specified in
	843	+	Section 567.3a of Title 59 of the Oklahoma Statutes, or a certified
	844	+	animal euthanasia technician as defined in Section 698.2 of Title 59
	845	+	of the Oklahoma Statutes, or an anim al control officer regis tered by
	846	+	the Oklahoma State Bureau of Narcotics and Dangerous Drugs Control
	847	+	under subsection B of Section 2-301 of this title within the
	848	+	parameters of such officer’s duties under Sections 501 throug h 508
	849	+	of Title 4 of the Oklahoma S tatutes;
	850	+	26. “Narcotic drug” means any of the following, whether
	851	+	produced directly or indirectly by extraction from substances of
	852	+	vegetable origin, or independently b y means of chemical synthesis,
	853	+	or by a combination of e xtraction and chemical synthesis:
	854	+	a. opium, coca leaves an d opiates,
	855	+	b. a compound, manufacture, salt, derivative or
	856	+	preparation of opium, coca leaves or opiates,
	857	+	c. cocaine, its salts, optical and geo metric isomers, and
	858	+	salts of isomers,
	859	+	d. ecgonine, its derivatives, their salts, isomers and
	860	+	salts of isomers, an d
	861	+	e. a substance, and any compound, manufacture, salt,
	862	+	derivative or preparation thereof, which is chemically
	863	+	identical with any of the substan ces referred to in
	864	+	subparagraphs a through d of this pa ragraph, except
	865	+
	866	+	ENGR. S. A. TO ENGR. H. B. NO. 3439 Page 18 1
	867	+	2
	868	+	3
	869	+	4
	870	+	5
	871	+	6
	872	+	7
	873	+	8
	874	+	9
	875	+	10
	876	+	11
	877	+	12
	878	+	13
	879	+	14
	880	+	15
	881	+	16
	882	+	17
	883	+	18
	884	+	19
	885	+	20
	886	+	21
	887	+	22
	888	+	23
	889	+	24
	890	+
	891	+	that the words “narcotic drug” as used in Section 2-
	892	+	101 et seq. of this title shall not include
	893	+	decocainized coca leaves or extracts of coca leaves,
	894	+	which extracts do not contain cocain e or ecgonine;
	895	+	27. “Opiate” or “opioid” means any Schedule II, III, IV or V
	896	+	substance having an addiction-forming or addiction-sustaining
	897	+	liability similar to morphine or being capable of conversion into a
	898	+	drug having such addiction-forming or addiction -sustaining
	899	+	liability. The terms do not include, unless specifically designated
	900	+	as controlled under the Uniform Co ntrolled Dangerous Substances Act,
	901	+	the dextrorotatory isomer of 3-methoxy-n-methyl-morphinan and its
	902	+	salts (dextromethorphan). The terms do in clude the racemic and
	903	+	levorotatory forms;
	904	+	28. “Opium poppy” means the plant of the speci es Papaver
	905	+	somniferum L., except the seeds thereof;
	906	+	29. “Peace officer” means a police officer, sheriff, deputy
	907	+	sheriff, district attorney’s investigator, investigato r from the
	908	+	Office of the Attorney General, or any other person elected or
	909	+	appointed by law to enforce any of the criminal laws of this state
	910	+	or of the United States;
	911	+	30. “Person” means an individual, corporation, government or
	912	+	governmental subdivision or agency, business trust, estate, trust,
	913	+	partnership or association, or any other legal ent ity;
	914	+
	915	+	ENGR. S. A. TO ENGR. H. B. NO. 3439 Page 19 1
	916	+	2
	917	+	3
	918	+	4
	919	+	5
	920	+	6
	921	+	7
	922	+	8
	923	+	9
	924	+	10
	925	+	11
	926	+	12
	927	+	13
	928	+	14
	929	+	15
	930	+	16
	931	+	17
	932	+	18
	933	+	19
	934	+	20
	935	+	21
	936	+	22
	937	+	23
	938	+	24
	939	+
	940	+	31. “Poppy straw” means all parts, except the seeds, of the
	941	+	opium poppy, after mowing;
	942	+	32. “Practitioner” means:
	943	+	a. (1) a medical doctor or osteopathic physicia n,
	944	+	(2) a dentist,
	945	+	(3) a podiatrist,
	946	+	(4) an optometrist,
	947	+	(5) a veterinarian,
	948	+	(6) a physician assistant or Advanced Practice
	949	+	Registered Nurse under the supervision of a
	950	+	licensed medical doctor or osteopathic physician,
	951	+	(7) a scientific investigator, or
	952	+	(8) any other person,
	953	+	licensed, registered or otherwise perm itted to
	954	+	prescribe, distribute, di spense, conduct research with
	955	+	respect to, use for scientific purposes or administer
	956	+	a controlled dangerous substance in the course of
	957	+	professional practice or research in this state, or
	958	+	b. a pharmacy, hospital, laboratory or other institution
	959	+	licensed, registered or otherwise per mitted to
	960	+	distribute, dispense, conduct research with respect
	961	+	to, use for scientific purposes or administer a
	962	+	controlled dangerous substance in the course of
	963	+	professional practice or research in thi s state;
	964	+
	965	+	ENGR. S. A. TO ENGR. H. B. NO. 3439 Page 20 1
	966	+	2
	967	+	3
	968	+	4
	969	+	5
	970	+	6
	971	+	7
	972	+	8
	973	+	9
	974	+	10
	975	+	11
	976	+	12
	977	+	13
	978	+	14
	979	+	15
	980	+	16
	981	+	17
	982	+	18
	983	+	19
	984	+	20
	985	+	21
	986	+	22
	987	+	23
	988	+	24
	989	+
	990	+	33. “Production” includes the manufacture, plant ing,
	991	+	cultivation, growing or harvesting of a controlled dangerous
	992	+	substance;
	993	+	34. “State” means the State of Oklahoma or any other state of
	994	+	the United States;
	995	+	35. “Ultimate user” means a person who lawfully possesses a
	996	+	controlled dangerous substance for t he person’s own use or for the
	997	+	use of a member of the person’s household or for administration to
	998	+	an animal owned by the person or by a member of the person’s
	999	+	household;
	1000	+	36. “Drug paraphernalia” means all equipment, products and
	1001	+	materials of any kind whic h are used, intended for use, or fashioned
	1002	+	specifically for use in planting, propagating, cultivating, growing,
	1003	+	harvesting, manufacturing, comp ounding, converting, producing,
	1004	+	processing, preparing, testing, analyzing, packaging, rep ackaging,
	1005	+	storing, containing, concealing, injecting, ingesting, inhaling or
	1006	+	otherwise introducing into the human body, a controlled dangerous
	1007	+	substance in violation o f the Uniform Controlled Dangerous
	1008	+	Substances Act inclu ding, but not limited to:
	1009	+	a. kits used, intended for use, or fashioned specifically
	1010	+	for use in planting, propagating, cultivating, growing
	1011	+	or harvesting of any species of plant which is a
	1012	+	controlled dangerous substance or from which a
	1013	+	controlled dangerous substance can be derived,
	1014	+
	1015	+	ENGR. S. A. TO ENGR. H. B. NO. 3439 Page 21 1
	1016	+	2
	1017	+	3
	1018	+	4
	1019	+	5
	1020	+	6
	1021	+	7
	1022	+	8
	1023	+	9
	1024	+	10
	1025	+	11
	1026	+	12
	1027	+	13
	1028	+	14
	1029	+	15
	1030	+	16
	1031	+	17
	1032	+	18
	1033	+	19
	1034	+	20
	1035	+	21
	1036	+	22
	1037	+	23
	1038	+	24
	1039	+
	1040	+	b. kits used, intended for use, or fashioned specifically
	1041	+	for use in manufacturing, compounding, converting,
	1042	+	producing, processing or preparing controlled
	1043	+	dangerous substances ,
	1044	+	c. isomerization devices used, intended for use, or
	1045	+	fashioned specifically for use in i ncreasing the
	1046	+	potency of any species of plant which is a controlled
	1047	+	dangerous substance,
	1048	+	d. testing equipment used, intended for use, or fashioned
	1049	+	specifically for use in identifying, or in analyzing
	1050	+	the strength, effectiv eness or purity of controlled
	1051	+	dangerous substances,
	1052	+	e. scales and balances used, intended for use, or
	1053	+	fashioned specifically for use in weighing or
	1054	+	measuring controlled dangerous substances,
	1055	+	f. diluents and adulterants, such as quinine
	1056	+	hydrochloride, manni tol, mannite, dextrose and
	1057	+	lactose, used, intended for use , or fashioned
	1058	+	specifically for use in cutting controlled dangerous
	1059	+	substances,
	1060	+	g. separation gins and sifters used, intended for use, or
	1061	+	fashioned specifically for use in removing twigs and
	1062	+	seeds from, or in otherwise cleaning or r efining,
	1063	+	marijuana,
	1064	+
	1065	+	ENGR. S. A. TO ENGR. H. B. NO. 3439 Page 22 1
	1066	+	2
	1067	+	3
	1068	+	4
	1069	+	5
	1070	+	6
	1071	+	7
	1072	+	8
	1073	+	9
	1074	+	10
	1075	+	11
	1076	+	12
	1077	+	13
	1078	+	14
	1079	+	15
	1080	+	16
	1081	+	17
	1082	+	18
	1083	+	19
	1084	+	20
	1085	+	21
	1086	+	22
	1087	+	23
	1088	+	24
	1089	+
	1090	+	h. blenders, bowls, containers, spoons and mixing devices
	1091	+	used, intended for use, or fashioned specifically for
	1092	+	use in compounding controlled dange rous substances,
	1093	+	i. capsules, balloons, envelopes and o ther containers
	1094	+	used, intended for use, or fashioned speci fically for
	1095	+	use in packaging small quantities of controlled
	1096	+	dangerous substances,
	1097	+	j. containers and other objects used, intended for use,
	1098	+	or fashioned specifically for use in parenterally
	1099	+	injecting controlled dangerous substances in to the
	1100	+	human body,
	1101	+	k. hypodermic syringes, needles and other objects used,
	1102	+	intended for use, or fashioned specifically for use in
	1103	+	parenterally injecting controlled dan gerous substances
	1104	+	into the human body,
	1105	+	l. objects used, intended for use, or fashioned
	1106	+	specifically for use in in gesting, inhaling or
	1107	+	otherwise introducing marijuana, cocaine, hashish or
	1108	+	hashish oil into the human body, such as:
	1109	+	(1) metal, wooden, acrylic, glass, stone, plastic or
	1110	+	ceramic pipes with or without screens, permanent
	1111	+	screens, hashish heads or punctured me tal bowls,
	1112	+	(2) water pipes,
	1113	+	(3) carburetion tubes and devices,
	1114	+
	1115	+	ENGR. S. A. TO ENGR. H. B. NO. 3439 Page 23 1
	1116	+	2
	1117	+	3
	1118	+	4
	1119	+	5
	1120	+	6
	1121	+	7
	1122	+	8
	1123	+	9
	1124	+	10
	1125	+	11
	1126	+	12
	1127	+	13
	1128	+	14
	1129	+	15
	1130	+	16
	1131	+	17
	1132	+	18
	1133	+	19
	1134	+	20
	1135	+	21
	1136	+	22
	1137	+	23
	1138	+	24
	1139	+
	1140	+	(4) smoking and carburetion masks,
	1141	+	(5) roach clips, meaning objects used to hold burning
	1142	+	material, such as a marijuana cigarette, that has
	1143	+	become too small or too short to be held in the
	1144	+	hand,
	1145	+	(6) miniature cocaine spoons and cocaine vials,
	1146	+	(7) chamber pipes,
	1147	+	(8) carburetor pipes,
	1148	+	(9) electric pipes,
	1149	+	(10) air-driven pipes,
	1150	+	(11) chillums,
	1151	+	(12) bongs, or
	1152	+	(13) ice pipes or chillers,
	1153	+	m. all hidden or novelty pipes, and
	1154	+	n. any pipe that has a tobacco bowl or chamber of less
	1155	+	than one-half (1/2) inch in diameter in which there is
	1156	+	any detectable residue of any controlled dangerous
	1157	+	substance as defined in this section or any other
	1158	+	substances not legal for possession or use;
	1159	+	provided, however, the term “drug paraphernalia” shall not include
	1160	+	separation gins intended for use in preparing tea or spice, clamps
	1161	+	used for constructing electrical equipme nt, water pipes designed for
	1162	+	ornamentation in which no detectable amount of an illegal su bstance
	1163	+	is found or pipes designed and used solely for smoking tobacco,
	1164	+
	1165	+	ENGR. S. A. TO ENGR. H. B. NO. 3439 Page 24 1
	1166	+	2
	1167	+	3
	1168	+	4
	1169	+	5
	1170	+	6
	1171	+	7
	1172	+	8
	1173	+	9
	1174	+	10
	1175	+	11
	1176	+	12
	1177	+	13
	1178	+	14
	1179	+	15
	1180	+	16
	1181	+	17
	1182	+	18
	1183	+	19
	1184	+	20
	1185	+	21
	1186	+	22
	1187	+	23
	1188	+	24
	1189	+
	1190	+	traditional pipes of an American Indian tribal religious ceremony,
	1191	+	or antique pipes that are th irty (30) years of age or older;
	1192	+	37. a. “Synthetic controlled substance” means a substance:
	1193	+	(1) the chemical structure of which is substantially
	1194	+	similar to the chemical structure of a controlled
	1195	+	dangerous substance in Schedule I or II,
	1196	+	(2) which has a stimulant, depressant, or
	1197	+	hallucinogenic effect on the cent ral nervous
	1198	+	system that is substan tially similar to or
	1199	+	greater than the stimulant, depressant or
	1200	+	hallucinogenic effect on the central nervous
	1201	+	system of a controlled dangerous substance in
	1202	+	Schedule I or II, or
	1203	+	(3) with respect to a particular person, which such
	1204	+	person represents or intends to have a stimulant,
	1205	+	depressant, or hallucinogenic effect on the
	1206	+	central nervous system that is substantially
	1207	+	similar to or greater than the stimulant,
	1208	+	depressant, or hallucinogenic effect on the
	1209	+	central nervous system of a controlled dangerous
	1210	+	substance in Schedule I or II.
	1211	+	b. The designation of gamma butyrolactone or any other
	1212	+	chemical as a precursor, pursuant to Section 2-322 of
	1213	+	this title, does not preclude a findin g pursuant to
	1214	+
	1215	+	ENGR. S. A. TO ENGR. H. B. NO. 3439 Page 25 1
	1216	+	2
	1217	+	3
	1218	+	4
	1219	+	5
	1220	+	6
	1221	+	7
	1222	+	8
	1223	+	9
	1224	+	10
	1225	+	11
	1226	+	12
	1227	+	13
	1228	+	14
	1229	+	15
	1230	+	16
	1231	+	17
	1232	+	18
	1233	+	19
	1234	+	20
	1235	+	21
	1236	+	22
	1237	+	23
	1238	+	24
	1239	+
	1240	+	subparagraph a of this paragraph that the chemical is
	1241	+	a synthetic controlle d substance.
	1242	+	c. “Synthetic controlled substance” does not include:
	1243	+	(1) a controlled dangerous substance,
	1244	+	(2) any substance for which there is an approved new
	1245	+	drug application,
	1246	+	(3) with respect to a particular person any
	1247	+	substance, if an exemption is in eff ect for
	1248	+	investigational use, for that person under the
	1249	+	provisions of Section 505 of the Federal Food,
	1250	+	Drug and Cosmetic Act, Title 21 of the United
	1251	+	States Code, Section 355, to the extent conduct
	1252	+	with respect to such subst ance is pursuant to
	1253	+	such exemption, or
	1254	+	(4) any substance to the extent not intended for
	1255	+	human consumption before such an exemption takes
	1256	+	effect with respect to that substance.
	1257	+	d. Prima facie evidence t hat a substance containing
	1258	+	salvia divinorum has been en hanced, concentrated or
	1259	+	chemically or physically altered s hall give rise to a
	1260	+	rebuttable presumption that the substance is a
	1261	+	synthetic controlled substance;
	1262	+	38. “Tetrahydrocannabinols” means all substances that have been
	1263	+	chemically synthesized to emulate the tetrahydrocannabinols of
	1264	+
	1265	+	ENGR. S. A. TO ENGR. H. B. NO. 3439 Page 26 1
	1266	+	2
	1267	+	3
	1268	+	4
	1269	+	5
	1270	+	6
	1271	+	7
	1272	+	8
	1273	+	9
	1274	+	10
	1275	+	11
	1276	+	12
	1277	+	13
	1278	+	14
	1279	+	15
	1280	+	16
	1281	+	17
	1282	+	18
	1283	+	19
	1284	+	20
	1285	+	21
	1286	+	22
	1287	+	23
	1288	+	24
	1289	+
	1290	+	marijuana, specifically including any tetrahydrocannabinols derived
	1291	+	from industrial hemp;
	1292	+	39. “Isomer” means the optical isomer, except as used in
	1293	+	subsections C and F of S ection 2-204 of this title and paragraph 4
	1294	+	of subsection A of Section 2-206 of this title. As used in
	1295	+	subsections C and F of Section 2-204 of this title, “isomer” means
	1296	+	the optical, positional or geometric isomer. As used in paragraph 4
	1297	+	of subsection A of Section 2-206 of this title, the term “isomer”
	1298	+	means the optical or geometric isomer;
	1299	+	40. “Hazardous materials” means materials, whether solid,
	1300	+	liquid or gas, which are toxic to human, animal, aquatic or plant
	1301	+	life, and the disposal of which materials i s controlled by state or
	1302	+	federal guidelines;
	1303	+	41. “Anhydrous ammonia” means any substance that exhibits
	1304	+	cryogenic evaporative behavior and tests positive for ammonia;
	1305	+	42. “Acute pain” means pain, whether resulting from disease,
	1306	+	accidental or intentional t rauma or other cause, that the
	1307	+	practitioner reasonably expects to last only a short perio d of time.
	1308	+	“Acute pain” does not include chronic pain, pain being treated as
	1309	+	part of cancer care, hospice or other end-of-life care, or pain
	1310	+	being treated as part of palliative care;
	1311	+	43. “Chronic pain” means pain that persists beyond the usual
	1312	+	course of an acute disease or heal ing of an injury. “Chronic pain”
	1313	+	may or may not be associated with an acute or chronic pathologic
	1314	+
	1315	+	ENGR. S. A. TO ENGR. H. B. NO. 3439 Page 27 1
	1316	+	2
	1317	+	3
	1318	+	4
	1319	+	5
	1320	+	6
	1321	+	7
	1322	+	8
	1323	+	9
	1324	+	10
	1325	+	11
	1326	+	12
	1327	+	13
	1328	+	14
	1329	+	15
	1330	+	16
	1331	+	17
	1332	+	18
	1333	+	19
	1334	+	20
	1335	+	21
	1336	+	22
	1337	+	23
	1338	+	24
	1339	+
	1340	+	process that causes continuous or intermitte nt pain over months or
	1341	+	years;
	1342	+	44. “Initial prescription” means a prescription issued to a
	1343	+	patient who:
	1344	+	a. has never previously been issued a prescription for
	1345	+	the drug or its pharmaceutical equivalent in the past
	1346	+	year, or
	1347	+	b. requires a prescription for the drug or its
	1348	+	pharmaceutical equivalent due to a surgica l procedure
	1349	+	or new acute event and has previously had a
	1350	+	prescription for the drug or its pharmaceutical
	1351	+	equivalent within the past year.
	1352	+	When determining whether a patient was previously issued a
	1353	+	prescription for a drug or its pharmaceutical equivalent, th e
	1354	+	practitioner shall consult with the patient and review t he medical
	1355	+	record and prescription monitoring information of the patient;
	1356	+	45. “Patient-provider agreement” means a written contract or
	1357	+	agreement that is executed between a practitioner and a patien t,
	1358	+	prior to the commencement of tr eatment for chronic pain using an
	1359	+	opioid drug as a means to:
	1360	+	a. explain the possible risk of development of physical
	1361	+	or psychological dependence in the patient and pre vent
	1362	+	the possible development of addiction,
	1363	+
	1364	+	ENGR. S. A. TO ENGR. H. B. NO. 3439 Page 28 1
	1365	+	2
	1366	+	3
	1367	+	4
	1368	+	5
	1369	+	6
	1370	+	7
	1371	+	8
	1372	+	9
	1373	+	10
	1374	+	11
	1375	+	12
	1376	+	13
	1377	+	14
	1378	+	15
	1379	+	16
	1380	+	17
	1381	+	18
	1382	+	19
	1383	+	20
	1384	+	21
	1385	+	22
	1386	+	23
	1387	+	24
	1388	+
	1389	+	b. document the understanding of both the pra ctitioner
	1390	+	and the patient regarding the patient-provider
	1391	+	agreement of the patient,
	1392	+	c. establish the rights of the patient in association
	1393	+	with treatment and the obligat ions of the patient in
	1394	+	relation to the responsible use, discontinuation of
	1395	+	use, and storage of opioid drugs, including any
	1396	+	restrictions on the refill of prescriptions or the
	1397	+	acceptance of opioid prescriptions from practitioners,
	1398	+	d. identify the specific me dications and other modes of
	1399	+	treatment, including physical therapy or exercise,
	1400	+	relaxation or psychological couns eling, that are
	1401	+	included as a part of the patient-provider agreement,
	1402	+	e. specify the measures the practitioner may employ to
	1403	+	monitor the compliance of the patient including, but
	1404	+	not limited to, rand om specimen screens and pill
	1405	+	counts, and
	1406	+	f. delineate the process for terminating the agreement,
	1407	+	including the consequences if the practitioner has
	1408	+	reason to believe that the patient is not complying
	1409	+	with the terms of the agreement. Compliance with the
	1410	+	“consent items” shall constitute a v alid, informed
	1411	+	consent for opioid therapy. The practitioner shall be
	1412	+	held harmless from civil litigation for failure to
	1413	+
	1414	+	ENGR. S. A. TO ENGR. H. B. NO. 3439 Page 29 1
	1415	+	2
	1416	+	3
	1417	+	4
	1418	+	5
	1419	+	6
	1420	+	7
	1421	+	8
	1422	+	9
	1423	+	10
	1424	+	11
	1425	+	12
	1426	+	13
	1427	+	14
	1428	+	15
	1429	+	16
	1430	+	17
	1431	+	18
	1432	+	19
	1433	+	20
	1434	+	21
	1435	+	22
	1436	+	23
	1437	+	24
	1438	+
	1439	+	treat pain if the event occurs because of nona dherence
	1440	+	by the patient with any of the provisions of t he
	1441	+	patient-provider agreement;
	1442	+	46. “Serious illness” means a medical illness or physical
	1443	+	injury or condition that substantially affects quality of life for
	1444	+	more than a short period of time. “Serious illness” includes, but
	1445	+	is not limited to, Alzheimer ’s disease or related dementias, lung
	1446	+	disease, cancer, heart f ailure, renal failure, liver failure or
	1447	+	chronic, unremitting or intractable pain such as neuropathic pain;
	1448	+	and
	1449	+	47. “Surgical procedure” means a procedure that is performed
	1450	+	for the purpose of struct urally altering the human body by incision
	1451	+	or destruction of tissues as part of the practice of medicine. This
	1452	+	term includes the diagnostic or therapeutic treatment of conditions
	1453	+	or disease processes by use of instruments such as lasers,
	1454	+	ultrasound, ionizing, radiation, scalpels, probes o r needles that
	1455	+	cause localized alteration or transportation of live human tissue by
	1456	+	cutting, burning, vaporizing, freezing, suturing, probing or
	1457	+	manipulating by closed reduction for major dislocations or
	1458	+	fractures, or otherwise altering by any mechanical, thermal, light-
	1459	+	based, electromagnetic or chemical means.
	1460	+	SECTION 5. It being immediately necessary for the preservation
	1461	+	of the public peace, health or safety, an emergency is hereby
	1462	+
	1463	+	ENGR. S. A. TO ENGR. H. B. NO. 3439 Page 30 1
	1464	+	2
	1465	+	3
	1466	+	4
	1467	+	5
	1468	+	6
	1469	+	7
	1470	+	8
	1471	+	9
	1472	+	10
	1473	+	11
	1474	+	12
	1475	+	13
	1476	+	14
	1477	+	15
	1478	+	16
	1479	+	17
	1480	+	18
	1481	+	19
	1482	+	20
	1483	+	21
	1484	+	22
	1485	+	23
	1486	+	24
	1487	+
	1488	+	declared to exist, by r eason whereof this act shall take effect and
	1489	+	be in full force from and after its passage and approval."
	1490	+	Passed the Senate the 19th day of April, 2022.
	1491	+
	1492	+
	1493	+
	1494	+	Presiding Officer of the Senate
	1495	+
	1496	+
	1497	+	Passed the House of Representatives the ____ day of __________,
	1498	+	2022.
	1499	+
	1500	+
	1501	+
	1502	+	Presiding Officer of the House
	1503	+	of Representatives
	1504	+
	1505	+	ENGR. H. B. NO. 3439 Page 1 1
	1506	+	2
	1507	+	3
	1508	+	4
	1509	+	5
	1510	+	6
	1511	+	7
	1512	+	8
	1513	+	9
	1514	+	10
	1515	+	11
	1516	+	12
	1517	+	13
	1518	+	14
	1519	+	15
	1520	+	16
	1521	+	17
	1522	+	18
	1523	+	19
	1524	+	20
	1525	+	21
	1526	+	22
	1527	+	23
	1528	+	24
	1529	+
	1530	+	ENGROSSED HOUSE
	1531	+	BILL NO. 3439 By: Kerbs of the House
	1532	+
	1533	+	and
	1534	+
	1535	+	Kidd of the Senate
	1536	+
	1537	+
	1538	+
	1539	+
	1540	+	[ industrial hemp – Oklahoma Industrial Hemp Program
	1541	+	- providing that the Oklahoma Conservation
	1542	+	Commission shall have jurisdiction over the
	1543	+	creation and verification of carbon credits from
	1544	+	the Oklahoma Industrial Hemp Program –
	1545	+	emergency ]
	1546	+
	1547	+
	1548	+
	1549	+
	1550	+	BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
	1551	+	SECTION 6. AMENDATORY 2 O.S. 2021, Section 3 -402, is
	1552	+	amended to read as follows:
	1553	+	Section 3-402. As used in the Oklahom a Industrial Hemp Program:
	1554	+	1. "Department" means the Oklahoma Department of Agriculture,
	1555	+	Food, and Forestry;
	1556	+	2. "Fiber" means the stalk of the industrial hemp plant and
	1557	+	does not include the flower or seeds of the plant;
	1558	+	3. "Flower" means the part of the industrial hemp plant that
	1559	+	contains the majority of the industrial hemp plant's
	1560	+	tetrahydrocannabinol and other cannabinoids ;
	1561	+
	1562	+	ENGR. H. B. NO. 3439 Page 2 1
	1563	+	2
	1564	+	3
	1565	+	4
	1566	+	5
	1567	+	6
	1568	+	7
	1569	+	8
	1570	+	9
	1571	+	10
	1572	+	11
	1573	+	12
	1574	+	13
	1575	+	14
	1576	+	15
	1577	+	16
	1578	+	17
	1579	+	18
	1580	+	19
	1581	+	20
	1582	+	21
	1583	+	22
	1584	+	23
	1585	+	24
	1586	+
	1587	+	4. "Grain" means all of the parts of an industrial hemp plant
	1588	+	except the stalk or the flower of the industrial hemp plant;
	1589	+	5. "Handling" means possessing or stor ing industrial hemp for
	1590	+	any period of time on premises owned, operated or controlled by a
	1591	+	person licensed to cultivate or process industrial hemp and al so
	1592	+	includes possessing or storing industrial he mp in a vehicle for any
	1593	+	period of time other than during its actual transport from the
	1594	+	premises of a licensed person to cultivat e or process industrial
	1595	+	hemp to the premises of another licensed person;
	1596	+	3. 6. "Industrial hemp" means the plant Cannabis sativ a L. and
	1597	+	any part of the plant, including the seeds there of, and all
	1598	+	derivatives, extracts, cannabinoids, isomers, acids, salts and salts
	1599	+	of isomers, whether growing or not, with a delta -9
	1600	+	tetrahydrocannabinol concentration of not more than three -tenths of
	1601	+	one percent (0.3%) on a dry-weight basis;
	1602	+	4. 7. "Licensee" means a person who holds a valid Industrial
	1603	+	Hemp License to grow industrial hemp under the Oklahoma Industrial
	1604	+	Hemp Program. A licensee shall have the ability to remediate
	1605	+	noncompliant industrial hemp with a delta-9 tetrahydrocannabinol
	1606	+	concentration of not more than one percent (1.0%) on a dry-weight
	1607	+	basis for retesting as set forth by the Department as long as the
	1608	+	noncompliant industrial hemp has a delta-9 tetrahydrocannabinol
	1609	+	concentration of not more than three-tenths of one percent (0.3%) on
	1610	+	a dry-weight basis after retesting, and the option to remediate the
	1611	+
	1612	+	ENGR. H. B. NO. 3439 Page 3 1
	1613	+	2
	1614	+	3
	1615	+	4
	1616	+	5
	1617	+	6
	1618	+	7
	1619	+	8
	1620	+	9
	1621	+	10
	1622	+	11
	1623	+	12
	1624	+	13
	1625	+	14
	1626	+	15
	1627	+	16
	1628	+	17
	1629	+	18
	1630	+	19
	1631	+	20
	1632	+	21
	1633	+	22
	1634	+	23
	1635	+	24
	1636	+
	1637	+	industrial hemp through the reasonable destruction of the flower or
	1638	+	shredding of the entire lot into a homogeneous biomass results in
	1639	+	the remediation of any par t of the industrial hemp plant that is
	1640	+	above three-tenths of one percent (0.3%) on a dry-weight basis. All
	1641	+	noncompliant hemp must be tracked and documented. The State Board
	1642	+	of Agriculture shall have jurisdiction over said remediation, which
	1643	+	includes, but is not limited to, destruction t hrough composting,
	1644	+	burning, or other regulated disposal methods if the industrial hemp
	1645	+	is not remediated into a final product before processing below
	1646	+	three-tenths of one percent (0.3%) on a dry -weight basis;
	1647	+	5. 8. "License" means authorization by the Depa rtment for any
	1648	+	person to grow and cultivate industrial hemp on a registered la nd
	1649	+	area as part of the Oklahoma Industrial Hemp Program; and
	1650	+	6. 9. "Processing" means converting industrial hemp into a
	1651	+	marketable form, includi ng the production of all derivati ves,
	1652	+	extracts, cannabinoids, isomers, acids, salts and salts of isomers.
	1653	+	SECTION 7. AMENDATORY 2 O.S. 2021, Section 3 -403, is
	1654	+	amended to read as follows:
	1655	+	Section 3-403. A. 1. A licensee is authorized to engage in
	1656	+	the growth, cultivation, handling or processing of industrial hemp
	1657	+	and may remediate noncompliant industrial hemp with a delta-9
	1658	+	tetrahydrocannabinol concentration of not mo re than one percent
	1659	+	(1.0%) on a dry-weight basis and prepare for retesting as set forth
	1660	+	by the Department as long as the noncompliant industrial hemp has a
	1661	+
	1662	+	ENGR. H. B. NO. 3439 Page 4 1
	1663	+	2
	1664	+	3
	1665	+	4
	1666	+	5
	1667	+	6
	1668	+	7
	1669	+	8
	1670	+	9
	1671	+	10
	1672	+	11
	1673	+	12
	1674	+	13
	1675	+	14
	1676	+	15
	1677	+	16
	1678	+	17
	1679	+	18
	1680	+	19
	1681	+	20
	1682	+	21
	1683	+	22
	1684	+	23
	1685	+	24
	1686	+
	1687	+	delta-9 tetrahydrocannabinol concentration of not more than three -
	1688	+	tenths of one percent (0.3%) on a dry-weight basis after re testing,
	1689	+	or all or part of the product is disposed of in the process of
	1690	+	remediation so that only a compliant product (with a delta-9
	1691	+	tetrahydrocannabinol concentration of not more than three -tenths of
	1692	+	one percent (0.3%) on a dry -weight basis) is left, or all disposable
	1693	+	waste is destroyed follow ing a remediation process.
	1694	+	2. A remediation facility shall be an option of the remediation
	1695	+	process. The licensee may remediate any non compliant industrial
	1696	+	hemp at its own facilities, affiliated facilities, or third -party
	1697	+	facilities as long as these facil ities are licensed and approved by
	1698	+	the State Board of Agriculture as a remediation facility. The State
	1699	+	Board of Agriculture shall be notified before any non compliant
	1700	+	industrial hemp is transported to a remediation facility. Retesting
	1701	+	of any noncompliant industrial hemp shall be done within sixty (60)
	1702	+	days post-harvest. Within seven (7) days of receiving notice of a
	1703	+	measured tetrahydrocannabinol concentration that exceeds the
	1704	+	acceptable hemp tetrahydrocannabinol level but is less than one
	1705	+	percent (1.0%), the licensed grower shall consent to the destruction
	1706	+	of all cannabis from that lot, or he or she may request remediation
	1707	+	and a post-harvest retest in a homogenized form in accordance with
	1708	+	the procedures established by the State Board of Agriculture. A
	1709	+	measured tetrahydrocannabinol concentration that exceeds one percent
	1710	+	(1.0%) shall require the licensed grower to properly dispose of al l
	1711	+
	1712	+	ENGR. H. B. NO. 3439 Page 5 1
	1713	+	2
	1714	+	3
	1715	+	4
	1716	+	5
	1717	+	6
	1718	+	7
	1719	+	8
	1720	+	9
	1721	+	10
	1722	+	11
	1723	+	12
	1724	+	13
	1725	+	14
	1726	+	15
	1727	+	16
	1728	+	17
	1729	+	18
	1730	+	19
	1731	+	20
	1732	+	21
	1733	+	22
	1734	+	23
	1735	+	24
	1736	+
	1737	+	cannabis from that lot. The retest fee shall be paid in an amount
	1738	+	established by the State Board of Agriculture. Samples with a
	1739	+	measured tetrahydrocannabinol concentration of one percent (1.0%) or
	1740	+	greater shall not be eligible for a post -harvest retest or
	1741	+	remediation and shall be destroye d.
	1742	+	3. Licensees are allowed to sell industrial hemp grain and
	1743	+	other industrial hemp derivatives that are either grown or processed
	1744	+	in the State of Oklahoma, that do not include the flower, for the
	1745	+	purpose of livestock feed and other animal consumption in the State
	1746	+	of Oklahoma.
	1747	+	4. The Oklahoma Conservation Commission shall have jurisdiction
	1748	+	over the creation and verification of carbon credits from the
	1749	+	Oklahoma Industrial Hemp Program. The Oklahoma Conservation
	1750	+	Commission shall develop rules to implement a pilot carbon credit
	1751	+	verification and trading program specific to Oklahoma industrial
	1752	+	hemp, and the Oklahoma Conservation Commission shall have the
	1753	+	authority and jurisdiction to approve and recognize o ther voluntary
	1754	+	programs for verification of carbon credits. These rules shall be
	1755	+	in place within sixty (60) days of the effective date of thi s act.
	1756	+	B. The activities performed under the Oklahoma Industrial Hemp
	1757	+	Program shall not subject the persons part icipating in the program
	1758	+	to criminal liability under the Uniform Controlled Dangerous
	1759	+	Substances Act. The exemption fr om criminal liability pr ovided for
	1760	+	in this subsection is a limited exemption that shall be strictly
	1761	+
	1762	+	ENGR. H. B. NO. 3439 Page 6 1
	1763	+	2
	1764	+	3
	1765	+	4
	1766	+	5
	1767	+	6
	1768	+	7
	1769	+	8
	1770	+	9
	1771	+	10
	1772	+	11
	1773	+	12
	1774	+	13
	1775	+	14
	1776	+	15
	1777	+	16
	1778	+	17
	1779	+	18
	1780	+	19
	1781	+	20
	1782	+	21
	1783	+	22
	1784	+	23
	1785	+	24
	1786	+
	1787	+	construed and shall not apply to an a ctivity that is not expressly
	1788	+	permitted under the Okl ahoma Industrial Hemp Program.
	1789	+	SECTION 8. AMENDATORY 2 O.S. 2021 , Section 3-408, is
	1790	+	amended to read as follows:
	1791	+	Section 3-408. A. The Department may deny, revoke or suspend a
	1792	+	license if the licensee:
	1793	+	1. Violates any provision of the Oklahoma Industrial Hemp
	1794	+	Program or rules adopted pursuant t o the program;
	1795	+	2. Engages in fraud or deception in the procurement of or
	1796	+	attempt to procure a license under this the Oklahoma Industrial Hem p
	1797	+	Program or provides false information on a license a pplication;
	1798	+	3. Refuses or fails to cooperate and assist the Department with
	1799	+	the inspection process;
	1800	+	4. Refuses or fails to provide any information required or
	1801	+	requested by the Department for purposes of the Oklahoma Industrial
	1802	+	Hemp Program;
173	1803		5. Knowingly provides false, misleading or incorrect
174	1804		information pertaini ng to the licensee's cul tivation, handling or
175	1805		processing of industrial hemp to the Department by any means,
176	1806		including information provided in any application form, report,
177	1807		record or inspection re quired or maintained for purposes of the
178	1808		Oklahoma Industrial Hemp Program;
179		-
180	1809		6. Fails to submit any report required by the Oklahoma
181		-	Industrial Hemp Program; or ENR. H. B. NO. 3439 Page 5
	1810	+	Industrial Hemp Program; or
	1811	+
	1812	+	ENGR. H. B. NO. 3439 Page 7 1
	1813	+	2
	1814	+	3
	1815	+	4
	1816	+	5
	1817	+	6
	1818	+	7
	1819	+	8
	1820	+	9
	1821	+	10
	1822	+	11
	1823	+	12
	1824	+	13
	1825	+	14
	1826	+	15
	1827	+	16
	1828	+	17
	1829	+	18
	1830	+	19
	1831	+	20
	1832	+	21
	1833	+	22
	1834	+	23
	1835	+	24
182	1836
183	1837		7. Fails to pay fees required by the Oklah oma Industrial Hemp
184	1838		Program.
185		-
186	1839		B. 1. A licensee that negligently violates the provisions of
187	1840		the Oklahoma Industrial Hemp Program shall not be subject to a
188	1841		criminal enforcement action If a sample of a licensee's industrial
189	1842		hemp tests higher than three -tenths of one percent (0.3%) but less
190	1843		than one percent (1.0%) on a dry-weight basis for delta-9
191	1844		tetrahydrocannabinol con centration, the licensee shall not be
192	1845		subject to any penalty under the Oklahoma Industrial Hemp Program if
193	1846		the crop is destroyed or remediated.
194		-
195	1847		2. A licensee that neg ligently violates the provisions of the
196	1848		Oklahoma Industrial Hemp Program three times in a ny five-year period
197	1849		shall be ineligible to obtain a license pursuant to the Oklahoma
198	1850		Industrial Hemp Program for a period of five (5) years beginning on
199	1851		the date of the third violation.
200		-
201	1852		C. Any person convicted of a felon y relating to a controlled
202	1853		substance under state or federal law shall be ineligible during the
203	1854		ten-year period following the date of conviction to participate in
204	1855		this program.
205		-
206		-	SECTION 4. AMENDATORY 63 O.S. 2021, Section 2-101, as
207		-	amended by Section 1, Chapter 222, O.S.L. 2021, is amended to read
208		-	as follows:
209		-
	1856	+	SECTION 9. AMENDATORY 63 O.S. 2021, Section 2 -101, is
	1857	+	amended to read as follows:
210	1858		Section 2-101. As used in the Uniform Controlled Dangerous
211	1859		Substances Act:
	1860	+
	1861	+	ENGR. H. B. NO. 3439 Page 8 1
	1862	+	2
	1863	+	3
	1864	+	4
	1865	+	5
	1866	+	6
	1867	+	7
	1868	+	8
	1869	+	9
	1870	+	10
	1871	+	11
	1872	+	12
	1873	+	13
	1874	+	14
	1875	+	15
	1876	+	16
	1877	+	17
	1878	+	18
	1879	+	19
	1880	+	20
	1881	+	21
	1882	+	22
	1883	+	23
	1884	+	24
212	1885
213	1886		1. "Administer" means the direct application of a controlled
214	1887		dangerous substance, whether by inje ction, inhalation, ingestion or
215	1888		any other means, to the body of a patient, animal or rese arch
216	1889		subject by:
217		-
218	1890		a. a practitioner (or, in the presence of the
219	1891		practitioner, by the authorized agent of the
220	1892		practitioner), or
221		-
222	1893		b. the patient or research subject at the direction and
223	1894		in the presence of the practitioner;
224		-
225	1895		2. "Agent" means a peace officer app ointed by and who acts o n
226		-	behalf of the Director of the Oklahoma State Bureau of Narcotics and ~~ENR. H. B. NO. 3439 Page 6~~
	1896	+	behalf of the Director of the Oklahoma State Bureau of Narcotics and
227	1897		Dangerous Drugs Control or an authorized person who acts on behalf
228	1898		of or at the direction of a person who manufactures, distrib utes,
229	1899		dispenses, prescribes, admin isters or uses for scien tific purposes
230	1900		controlled dangerous substances but does not include a common or
231	1901		contract carrier, public warehouser or employee thereof, or a p erson
232	1902		required to register under the Uniform Controlled Dangerous
233	1903		Substances Act;
234		-
235	1904		3. "Board" means the Advisory Board to the Director of the
236	1905		Oklahoma State Bureau of Narcotics and Dangerous Drugs Control;
237		-
238	1906		4. "Bureau" means the Oklahoma State Bureau of Na rcotics and
239	1907		Dangerous Drugs Control;
240		-
241	1908		5. "Coca leaves" includes cocaine and any compound,
242	1909		manufacture, salt, deri vative, mixture or preparation of coca
	1910	+
	1911	+	ENGR. H. B. NO. 3439 Page 9 1
	1912	+	2
	1913	+	3
	1914	+	4
	1915	+	5
	1916	+	6
	1917	+	7
	1918	+	8
	1919	+	9
	1920	+	10
	1921	+	11
	1922	+	12
	1923	+	13
	1924	+	14
	1925	+	15
	1926	+	16
	1927	+	17
	1928	+	18
	1929	+	19
	1930	+	20
	1931	+	21
	1932	+	22
	1933	+	23
	1934	+	24
	1935	+
243	1936		leaves, except derivatives of coca leaves which do not contain
244	1937		cocaine or ecgonine;
245		-
246	1938		6. "Commissioner" o r "Director" means the Director of the
247	1939		Oklahoma State Bureau of Narcotics and Dangerous D rugs Control;
248		-
249	1940		7. "Control" means to add, remove or change the placement of a
250	1941		drug, substance or immediate precursor under the Uniform Controlled
251	1942		Dangerous Substances Act;
252		-
253	1943		8. "Controlled dangerous substance" means a drug, substance or
254	1944		immediate precursor in Schedules I through V of the Uniform
255	1945		Controlled Dangerous Substances Act or any drug, substance or
256	1946		immediate precursor listed either temporarily or permanently as a
257	1947		federally controlled substance. Any conflict between state and
258	1948		federal law with regard to the particular schedu le in which a
259	1949		substance is listed shall be resolved in favor of state law;
260		-
261	1950		9. "Counterfeit substance" means a controlled substance which,
262	1951		or the container or labeling of which without authorization , bears
263	1952		the trademark, trade name or other identifying mar ks, imprint,
264	1953		number or device or any likeness thereof of a manufacturer,
265	1954		distributor or dispenser other than the person who in fact
266	1955		manufactured, distributed or dispensed the substance;
267		-
268	1956		10. "Deliver" or "delivery" means the actual, constructive or
269	1957		attempted transfer from one person to another of a controlled
270	1958		dangerous substance or drug paraphernalia, whether or not there is
271		-	an agency relationship; ENR. H. B. NO. 3439 Page 7
	1959	+	an agency relationshi p;
	1960	+
	1961	+	ENGR. H. B. NO. 3439 Page 10 1
	1962	+	2
	1963	+	3
	1964	+	4
	1965	+	5
	1966	+	6
	1967	+	7
	1968	+	8
	1969	+	9
	1970	+	10
	1971	+	11
	1972	+	12
	1973	+	13
	1974	+	14
	1975	+	15
	1976	+	16
	1977	+	17
	1978	+	18
	1979	+	19
	1980	+	20
	1981	+	21
	1982	+	22
	1983	+	23
	1984	+	24
272	1985
273	1986		11. "Dispense" means to deliver a controlled danger ous
274	1987		substance to an ultimate user or human research subjec t by or
275	1988		pursuant to the lawful order of a practitioner, including the
276	1989		prescribing, administering, packaging, labeling or compounding
277	1990		necessary to prepare the substance for such distribution.
278	1991		"Dispenser" is a practitioner who delive rs a controlled dangerou s
279	1992		substance to an ultimate user or human research subject;
280		-
281	1993		12. "Distribute" means to deliver other than by administering
282	1994		or dispensing a contr olled dangerous substance;
283		-
284	1995		13. "Distributor" means a c ommercial entity engaged in the
285	1996		distribution or reverse di stribution of narcotics and dangerous
286	1997		drugs and who complies with all regulations promulgated by the
287	1998		federal Drug Enforcement Administration an d the Oklahoma State
288	1999		Bureau of Narcotics and Dangerous Drugs Control;
289		-
290	2000		14. "Drug" means articles:
291		-
292	2001		a. recognized in the official United States Pharmacopeia,
293	2002		official Homeopathic Pharmacopoeia of the United
294	2003		States, or official National Formulary, or any
295	2004		supplement to any of them,
296		-
297	2005		b. intended for use in the diagn osis, cure, mitigation,
298	2006		treatment or prevention of disease in man or other
299	2007		animals,
300		-
301	2008		c. other than food, intended to affect the structure or
302	2009		any function of the body of man or other animals, and
303	2010
	2011	+	ENGR. H. B. NO. 3439 Page 11 1
	2012	+	2
	2013	+	3
	2014	+	4
	2015	+	5
	2016	+	6
	2017	+	7
	2018	+	8
	2019	+	9
	2020	+	10
	2021	+	11
	2022	+	12
	2023	+	13
	2024	+	14
	2025	+	15
	2026	+	16
	2027	+	17
	2028	+	18
	2029	+	19
	2030	+	20
	2031	+	21
	2032	+	22
	2033	+	23
	2034	+	24
	2035	+
304	2036		d. intended for use as a component of any article
305	2037		specified in this paragraph;
306		-
307	2038		provided, however, the term "drug" does n ot include devices or their
308	2039		components, parts or accessories;
309		-
310	2040		15. "Drug-dependent person" means a person who is using a
311	2041		controlled dangerous s ubstance and who is in a state of psychic or
312	2042		physical dependence, or both, arising from a dministration of that
313	2043		controlled dangerous substance on a continuous basis. Drug
314	2044		dependence is characterized by behavioral and other responses which
315		-	include a strong compulsion to take the substance on a continuous ~~ENR. H. B. NO. 3439 Page 8~~
	2045	+	include a strong compulsion to take the substance on a continuous
316	2046		basis in order to experience its psychic effects, or to avoid th e
317	2047		discomfort of its absence;
318		-
319	2048		16. "Home care agency" means any sole proprietorship,
320	2049		partnership, association, corporation, or other organizatio n which
321	2050		administers, offers, or provides home care serv ices, for a fee or
322	2051		pursuant to a contract for such service s, to clients in their place
323	2052		of residence;
324		-
325	2053		17. "Home care services" means skilled or personal care
326	2054		services provided to clients in their place of residence for a fee;
327		-
328	2055		18. "Hospice" means a central ly administered, nonprofit or for -
329	2056		profit, medically direct ed, nurse-coordinated program which provides
330	2057		a continuum of home and inpatient care for the terminally ill
331	2058		patient and the patient's family. S uch term shall also include a
332	2059		centrally administered, n onprofit or for-profit, medically directed,
	2060	+
	2061	+	ENGR. H. B. NO. 3439 Page 12 1
	2062	+	2
	2063	+	3
	2064	+	4
	2065	+	5
	2066	+	6
	2067	+	7
	2068	+	8
	2069	+	9
	2070	+	10
	2071	+	11
	2072	+	12
	2073	+	13
	2074	+	14
	2075	+	15
	2076	+	16
	2077	+	17
	2078	+	18
	2079	+	19
	2080	+	20
	2081	+	21
	2082	+	22
	2083	+	23
	2084	+	24
	2085	+
333	2086		nurse-coordinated program if such program is licensed pursuant to
334	2087		the provisions of the Uniform Controlled Dangerous Substances Act.
335	2088		A hospice program offer s palliative and supportive care to meet the
336	2089		special needs arising out of the physical, e motional and spiritual
337	2090		stresses which are experienced during the final stages of illness
338	2091		and during dying and bereavement. This care is available twenty -
339	2092		four (24) hours a day, seven (7) days a week, and is provided on the
340	2093		basis of need, regardless of abil ity to pay. "Class A" H ospice
341	2094		refers to Medicare-certified hospices. "Class B" refers to all
342	2095		other providers of hospice services;
343		-
344	2096		19. "Imitation controlled substanc e" means a substance that is
345	2097		not a controlled dangerous substance, which by dosage unit
346	2098		appearance, color, shape, size, markings or by representations made,
347	2099		would lead a reasonable person to believe that the substance is a
348	2100		controlled dangerous substance. In the event the appearance of the
349	2101		dosage unit is not r easonably sufficient to establish that the
350	2102		substance is an "imitation controlled substance", the court or
351	2103		authority concerned should consider, in addition to all other
352	2104		factors, the following factors as related to "representations made"
353	2105		in determining wheth er the substance is an "imitation controlled
354	2106		substance":
355		-
356	2107		a. statements made by an owner or by any other person in
357	2108		control of the substance concerning the nature of the
358	2109		substance, or its use or effect,
359		-	ENR. H. B. NO. 3439 Page 9
	2110	+
	2111	+	ENGR. H. B. NO. 3439 Page 13 1
	2112	+	2
	2113	+	3
	2114	+	4
	2115	+	5
	2116	+	6
	2117	+	7
	2118	+	8
	2119	+	9
	2120	+	10
	2121	+	11
	2122	+	12
	2123	+	13
	2124	+	14
	2125	+	15
	2126	+	16
	2127	+	17
	2128	+	18
	2129	+	19
	2130	+	20
	2131	+	21
	2132	+	22
	2133	+	23
	2134	+	24
	2135	+
360	2136		b. statements made to the recipient that the substance
361	2137		may be resold for inordinate profi t,
362		-
363	2138		c. whether the substance is packaged in a manner normally
364	2139		used for illicit controlled substances,
365		-
366	2140		d. evasive tactics or actions utilized by the owner or
367	2141		person in control of the substance to avoid detection
368	2142		by law enforcement authorities,
369		-
370	2143		e. prior convictions, if any, of an ow ner, or any other
371	2144		person in control of the object, under state or
372	2145		federal law related to controlled substances or fraud,
373	2146		and
374		-
375	2147		f. the proximity of the substances to controlled
376	2148		dangerous substances;
377		-
378	2149		20. "Immediate precursor" means a s ubstance which the Direc tor
379	2150		has found to be and by regulation designates as being the principal
380	2151		compound commonly used or produced primarily for use, and which is
381	2152		an immediate chemical intermediary used, or likely to be us ed, in
382	2153		the manufacture of a contro lled dangerous substance , the control of
383	2154		which is necessary to prevent, curtail or limit such manufacture;
384		-
385	2155		21. "Laboratory" means a laboratory approved by the Directo r as
386	2156		proper to be entrusted with the custody of control led dangerous
387	2157		substances and the u se of controlled dangero us substances for
388	2158		scientific and medical purposes and for purposes of instruction;
	2159	+
	2160	+	ENGR. H. B. NO. 3439 Page 14 1
	2161	+	2
	2162	+	3
	2163	+	4
	2164	+	5
	2165	+	6
	2166	+	7
	2167	+	8
	2168	+	9
	2169	+	10
	2170	+	11
	2171	+	12
	2172	+	13
	2173	+	14
	2174	+	15
	2175	+	16
	2176	+	17
	2177	+	18
	2178	+	19
	2179	+	20
	2180	+	21
	2181	+	22
	2182	+	23
	2183	+	24
389	2184
390	2185		22. "Manufacture" means the production, preparation,
391	2186		propagation, compounding or processing of a controlled danger ous
392	2187		substance, either directly or indirectly by extraction from
393	2188		substances of natural or synthetic origin, or independently by means
394	2189		of chemical synthesis or by a combination of extraction and chemical
395	2190		synthesis. "Manufacturer" includes any person who pac kages,
396	2191		repackages or labels any co ntainer of any controlle d dangerous
397	2192		substance, except practitioners who dispense or compound
398	2193		prescription orders for delivery to the ultimate consumer;
399		-
400	2194		23. "Marijuana" means all parts of the plant Cannabis sativa
401	2195		L., whether growing or not; the seeds ther eof; the resin extracted
402	2196		from any part of such plant; and every compound, manufacture, salt,
403	2197		derivative, mixture or preparation of such plant, its seeds or
404		-	resin, but shall not include: ENR. H. B. NO. 3439 Page 10
405		-
	2198	+	resin, but shall not include:
406	2199		a. the mature stalks of such plant o r fiber produced from
407	2200		such stalks,
408		-
409	2201		b. oil or cake made fro m the seeds of such plant,
410	2202		including cannabidiol derived from the seeds of the
411	2203		marijuana plant,
412		-
413	2204		c. any other compound, manufacture, salt, deriv ative,
414	2205		mixture or preparation of such mature stalks (ex cept
415	2206		the resin extracted therefrom ), including cannabidiol
416	2207		derived from mature stalks, fiber, oil or cake,
417	2208
	2209	+	ENGR. H. B. NO. 3439 Page 15 1
	2210	+	2
	2211	+	3
	2212	+	4
	2213	+	5
	2214	+	6
	2215	+	7
	2216	+	8
	2217	+	9
	2218	+	10
	2219	+	11
	2220	+	12
	2221	+	13
	2222	+	14
	2223	+	15
	2224	+	16
	2225	+	17
	2226	+	18
	2227	+	19
	2228	+	20
	2229	+	21
	2230	+	22
	2231	+	23
	2232	+	24
	2233	+
418	2234		d. the sterilized seed of such plant which is incapable
419	2235		of germination,
420		-
421	2236		e. for any person participating in a clinical trial to
422	2237		administer cannabidiol for the treatment of severe
423	2238		forms of epilepsy pursuant to Section 2-802 of this
424	2239		title, a drug or substance approved by the federal
425	2240		Food and Drug Administration for use by those
426	2241		participants,
427		-
428	2242		f. for any person or the parents, legal guardians or
429	2243		caretakers of the person who have received a written
430	2244		certification from a physician licensed in this state
431	2245		that the person has been diagnosed by a physician as
432	2246		having Lennox-Gastaut syndrome, Dravet syndrome, als o
433	2247		known as severe myoclonic epilepsy of infancy, or any
434	2248		other severe form of epilepsy tha t is not adequately
435	2249		treated by traditional medical therapies, spasticity
436	2250		due to multiple sclerosis or due to paraplegia,
437	2251		intractable nausea and vomiting, appetite stim ulation
438	2252		with chronic wasting diseases, the substance
439	2253		cannabidiol, a nonpsychoactive canna binoid, found in
440	2254		the plant Cannabis sativa L. or any other preparation
441	2255		thereof, that has a tetrahydrocannabinol concentration
442	2256		of not more than three -tenths of one percent (0.3%)
	2257	+
	2258	+	ENGR. H. B. NO. 3439 Page 16 1
	2259	+	2
	2260	+	3
	2261	+	4
	2262	+	5
	2263	+	6
	2264	+	7
	2265	+	8
	2266	+	9
	2267	+	10
	2268	+	11
	2269	+	12
	2270	+	13
	2271	+	14
	2272	+	15
	2273	+	16
	2274	+	17
	2275	+	18
	2276	+	19
	2277	+	20
	2278	+	21
	2279	+	22
	2280	+	23
	2281	+	24
	2282	+
443	2283		and that is delivered to the patient in the form of a
444	2284		liquid,
445		-
446	2285		g. any federal Food-and-Drug-Administration-approved drug
447	2286		or substance, or
448		-	ENR. H. B. NO. 3439 Page 11
449	2287		h. industrial hemp, from the plant Cannabis sativa L. and
450	2288		any part of such plant, whether growing or not, wi th a
451	2289		delta-9 tetrahydrocannabinol concentration of not more
452		-	than three-tenths of one percent (0.3%) on a dry
453		-	weight dry-weight basis which shall only be grown
454		-	pursuant to the Oklahoma Industrial Hemp Program and
455		-	may be shipped intrastate and interstate;
456		-
	2290	+	than three-tenths of one percent (0.3%) on a dry-
	2291	+	weight basis which shall only be grown pursuant to the
	2292	+	Oklahoma Industrial Hemp Program and may be shipped
	2293	+	intrastate and interstate;
457	2294		24. "Medical purpose" means an intention to utilize a
458	2295		controlled dangerous substance for physical or mental treatment, for
459	2296		diagnosis, or for the prevention of a disease condition not in
460	2297		violation of any state or federal law and not for the purpose of
461	2298		satisfying physiological or psychological dependence or other abuse;
462		-
463	2299		25. "Mid-level practitioner" means a n Advanced Practice
464	2300		Registered Nurse as defined and within parameters specified in
465	2301		Section 567.3a of Title 59 of the Oklahoma Statutes, or a certified
466	2302		animal euthanasia technician as defined in Section 698.2 of Title 59
467	2303		of the Oklahoma Statutes, or an anim al control officer regis tered by
468	2304		the Oklahoma State Bureau of Narcotics and Dangerous Drugs Control
469	2305		under subsection B of Section 2 -301 of this title within the
	2306	+
	2307	+	ENGR. H. B. NO. 3439 Page 17 1
	2308	+	2
	2309	+	3
	2310	+	4
	2311	+	5
	2312	+	6
	2313	+	7
	2314	+	8
	2315	+	9
	2316	+	10
	2317	+	11
	2318	+	12
	2319	+	13
	2320	+	14
	2321	+	15
	2322	+	16
	2323	+	17
	2324	+	18
	2325	+	19
	2326	+	20
	2327	+	21
	2328	+	22
	2329	+	23
	2330	+	24
	2331	+
470	2332		parameters of such officer's duties under Sections 501 throug h 508
471	2333		of Title 4 of the Oklahoma S tatutes;
472		-
473	2334		26. "Narcotic drug" means any of the following, whether
474	2335		produced directly or indirectly by extraction from substances of
475	2336		vegetable origin, or independently b y means of chemical synthesis,
476	2337		or by a combination of e xtraction and chemical synthesis:
477		-
478	2338		a. opium, coca leaves an d opiates,
479		-
480	2339		b. a compound, manufacture, salt, derivative or
481	2340		preparation of opium, coca leaves or opiates,
482		-
483	2341		c. cocaine, its salts, optical and geo metric isomers, and
484	2342		salts of isomers,
485		-
486	2343		d. ecgonine, its derivatives, their salts, isomers and
487	2344		salts of isomers, an d
488		-
489	2345		e. a substance, and any compound, manufacture, salt,
490	2346		derivative or preparation thereof, which is chemically
491	2347		identical with any of the substan ces referred to in
492	2348		subparagraphs a through d of this pa ragraph, except
493		-	that the words "narcotic drug" as used in Section 2- ~~ENR. H. B. NO. 3439 Page 12~~
	2349	+	that the words "narcotic drug" as used in Section 2-
494	2350		101 et seq. of this title shall not include
495	2351		decocainized coca leaves or extracts of coca leaves,
496	2352		which extracts do not contain cocain e or ecgonine;
497		-
498	2353		27. "Opiate" or "opioid" means any Sche dule II, III, IV or V
499	2354		substance having an addiction-forming or addiction-sustaining
500	2355		liability similar to morphine or being capable of conversion into a
	2356	+
	2357	+	ENGR. H. B. NO. 3439 Page 18 1
	2358	+	2
	2359	+	3
	2360	+	4
	2361	+	5
	2362	+	6
	2363	+	7
	2364	+	8
	2365	+	9
	2366	+	10
	2367	+	11
	2368	+	12
	2369	+	13
	2370	+	14
	2371	+	15
	2372	+	16
	2373	+	17
	2374	+	18
	2375	+	19
	2376	+	20
	2377	+	21
	2378	+	22
	2379	+	23
	2380	+	24
	2381	+
501	2382		drug having such addiction -forming or addiction -sustaining
502	2383		liability. The terms do not include, unless specifically designated
503	2384		as controlled under the Uniform Co ntrolled Dangerous Substances Act,
504	2385		the dextrorotatory isomer of 3-methoxy-n-methyl-morphinan and its
505	2386		salts (dextromethorphan). The terms do in clude the racemic and
506	2387		levorotatory forms;
507		-
508	2388		28. "Opium poppy" means the plant of the speci es Papaver
509	2389		somniferum L., except the seeds thereof;
510		-
511	2390		29. "Peace officer" means a police officer, sheriff, deputy
512	2391		sheriff, district attorney's investigator, investigato r from the
513	2392		Office of the Attorney General, or any other person elected or
514	2393		appointed by law to enforce any of the criminal laws of this state
515	2394		or of the United States;
516		-
517	2395		30. "Person" means an individual, corporation, government or
518	2396		governmental subdivision or agency, business trust, estate, trust,
519	2397		partnership or association, or any other legal ent ity;
520		-
521	2398		31. "Poppy straw" means all parts, except the seeds, of the
522	2399		opium poppy, after mowing;
523		-
524	2400		32. "Practitioner" means:
525		-
526	2401		a. (1) a medical doctor or osteopathic physicia n,
527		-
528	2402		(2) a dentist,
529		-
530	2403		(3) a podiatrist,
531		-
532	2404		(4) an optometrist,
533		-
534	2405		(5) a veterinarian,
	2406	+
	2407	+	ENGR. H. B. NO. 3439 Page 19 1
	2408	+	2
	2409	+	3
	2410	+	4
	2411	+	5
	2412	+	6
	2413	+	7
	2414	+	8
	2415	+	9
	2416	+	10
	2417	+	11
	2418	+	12
	2419	+	13
	2420	+	14
	2421	+	15
	2422	+	16
	2423	+	17
	2424	+	18
	2425	+	19
	2426	+	20
	2427	+	21
	2428	+	22
	2429	+	23
	2430	+	24
535	2431
536	2432		(6) a physician assistant or Advanced Practice
537	2433		Registered Nurse under the supervision of a
538		-	licensed medical doctor or osteopathic physician, ENR. H. B. NO. 3439 Page 13
539		-
	2434	+	licensed medical doctor or osteopathic physician,
540	2435		(7) a scientific investigator, or
541		-
542	2436		(8) any other person,
543		-
544	2437		licensed, registered or otherwise perm itted to
545	2438		prescribe, distribute, di spense, conduct research with
546	2439		respect to, use for scientific purposes or administer
547	2440		a controlled dangerous substance in the course of
548	2441		professional practice or research in this state, or
549		-
550	2442		b. a pharmacy, hospital, laboratory or other institution
551	2443		licensed, registered or otherwise per mitted to
552	2444		distribute, dispense, conduct research with respect
553	2445		to, use for scientific purposes or administer a
554	2446		controlled dangerous substance in the course of
555	2447		professional practice or research in thi s state;
556		-
557	2448		33. "Production" include s the manufacture, plant ing,
558	2449		cultivation, growing or harvesting of a controlled dangerous
559	2450		substance;
560		-
561	2451		34. "State" means the State of Oklahoma or any other state of
562	2452		the United States;
563		-
564	2453		35. "Ultimate user" means a person who lawfully possesses a
565	2454		controlled dangerous substance for t he person's own use or for the
566	2455		use of a member of the person's household or for administration to
	2456	+
	2457	+	ENGR. H. B. NO. 3439 Page 20 1
	2458	+	2
	2459	+	3
	2460	+	4
	2461	+	5
	2462	+	6
	2463	+	7
	2464	+	8
	2465	+	9
	2466	+	10
	2467	+	11
	2468	+	12
	2469	+	13
	2470	+	14
	2471	+	15
	2472	+	16
	2473	+	17
	2474	+	18
	2475	+	19
	2476	+	20
	2477	+	21
	2478	+	22
	2479	+	23
	2480	+	24
	2481	+
567	2482		an animal owned by the person or by a member of the person's
568	2483		household;
569		-
570	2484		36. "Drug paraphernalia" me ans all equipment, products and
571	2485		materials of any kind whic h are used, intended for use, or fashioned
572	2486		specifically for use in planting, propagating, cultivating, growing,
573	2487		harvesting, manufacturing, comp ounding, converting, producing,
574	2488		processing, preparing, testing, analyzing, packaging, rep ackaging,
575	2489		storing, containing, concealing, injecting, ingesting, inhaling or
576	2490		otherwise introducing into the human body, a controlled dangerous
577	2491		substance in violation o f the Uniform Controlled Dangerous
578	2492		Substances Act inclu ding, but not limited to:
579		-
580	2493		a. kits used, intended for use, or fashioned specifically
581	2494		for use in planting, propagating, cultivating, growing
582		-	or harvesting of any species of plant which is a ~~ENR. H. B. NO. 3439 Page 14~~
	2495	+	or harvesting of any species of plant which is a
583	2496		controlled dangerous substance or from which a
584	2497		controlled dangerous substance can be derived,
585		-
586	2498		b. kits used, intended for use, or fashioned specifically
587	2499		for use in manufacturing, compounding, converting,
588	2500		producing, processing or preparing controlled
589	2501		dangerous substances ,
590		-
591	2502		c. isomerization devices used, intended for use, or
592	2503		fashioned specifically for use in i ncreasing the
593	2504		potency of any species of plant which is a controlled
594	2505		dangerous substance,
595	2506
	2507	+	ENGR. H. B. NO. 3439 Page 21 1
	2508	+	2
	2509	+	3
	2510	+	4
	2511	+	5
	2512	+	6
	2513	+	7
	2514	+	8
	2515	+	9
	2516	+	10
	2517	+	11
	2518	+	12
	2519	+	13
	2520	+	14
	2521	+	15
	2522	+	16
	2523	+	17
	2524	+	18
	2525	+	19
	2526	+	20
	2527	+	21
	2528	+	22
	2529	+	23
	2530	+	24
	2531	+
596	2532		d. testing equipment used, intended for use, or fashioned
597	2533		specifically for use in identifying, or in analyzing
598	2534		the strength, effectiv eness or purity of controlled
599	2535		dangerous substances,
600		-
601	2536		e. scales and balances used, intended for use, or
602	2537		fashioned specifically for use in weighing or
603	2538		measuring controlled dangerous substances,
604		-
605	2539		f. diluents and adulterants, such as quinine
606	2540		hydrochloride, manni tol, mannite, dextrose and
607	2541		lactose, used, intended for use , or fashioned
608	2542		specifically for use in cutting controlled dangerous
609	2543		substances,
610		-
611	2544		g. separation gins and sifters used, intended for use, or
612	2545		fashioned specifically for use in removing twigs and
613	2546		seeds from, or in otherwise cleaning or r efining,
614	2547		marijuana,
615		-
616	2548		h. blenders, bowls, containers, spoons and mixing devices
617	2549		used, intended for use, or fashioned specifically for
618	2550		use in compounding controlled dange rous substances,
619		-
620	2551		i. capsules, balloons, envelopes and o ther containers
621	2552		used, intended for use, or fashioned speci fically for
622	2553		use in packaging small quantities of controlled
623	2554		dangerous substances,
624	2555
	2556	+	ENGR. H. B. NO. 3439 Page 22 1
	2557	+	2
	2558	+	3
	2559	+	4
	2560	+	5
	2561	+	6
	2562	+	7
	2563	+	8
	2564	+	9
	2565	+	10
	2566	+	11
	2567	+	12
	2568	+	13
	2569	+	14
	2570	+	15
	2571	+	16
	2572	+	17
	2573	+	18
	2574	+	19
	2575	+	20
	2576	+	21
	2577	+	22
	2578	+	23
	2579	+	24
	2580	+
625	2581		j. containers and other objects used, intended for use,
626		-	or fashioned specifically for use in parenterally ~~ENR. H. B. NO. 3439 Page 15~~
	2582	+	or fashioned specifically for use in parenterally
627	2583		injecting controlled dangerous substances in to the
628	2584		human body,
629		-
630	2585		k. hypodermic syringes, needles and other objects used,
631	2586		intended for use, or fashioned specifically for use in
632	2587		parenterally injecting controlled dan gerous substances
633	2588		into the human body,
634		-
635	2589		l. objects used, intended for use, or fashioned
636	2590		specifically for use in in gesting, inhaling or
637	2591		otherwise introducing marijuana, cocaine, hashish or
638	2592		hashish oil into the human body, such as:
639		-
640	2593		(1) metal, wooden, acrylic, glass, stone, plastic or
641	2594		ceramic pipes with or without screens, permanent
642	2595		screens, hashish heads or punctured me tal bowls,
643		-
644	2596		(2) water pipes,
645		-
646	2597		(3) carburetion tubes and devices,
647		-
648	2598		(4) smoking and carburetion masks,
649		-
650	2599		(5) roach clips, meaning objects used to hold burning
651	2600		material, such as a marijuana cigarette, that has
652	2601		become too small or too short to be held in the
653	2602		hand,
654		-
655	2603		(6) miniature cocaine spoons and cocaine vials,
656		-
657	2604		(7) chamber pipes,
658	2605
	2606	+	ENGR. H. B. NO. 3439 Page 23 1
	2607	+	2
	2608	+	3
	2609	+	4
	2610	+	5
	2611	+	6
	2612	+	7
	2613	+	8
	2614	+	9
	2615	+	10
	2616	+	11
	2617	+	12
	2618	+	13
	2619	+	14
	2620	+	15
	2621	+	16
	2622	+	17
	2623	+	18
	2624	+	19
	2625	+	20
	2626	+	21
	2627	+	22
	2628	+	23
	2629	+	24
	2630	+
659	2631		(8) carburetor pipes,
660		-
661	2632		(9) electric pipes,
662		-
663	2633		(10) air-driven pipes,
664		-
665	2634		(11) chillums,
666		-
667	2635		(12) bongs, or
668		-
669	2636		(13) ice pipes or chillers,
670		-
671		-	m. all hidden or novelty pipes, and ENR. H. B. NO. 3439 Page 16
672		-
	2637	+	m. all hidden or novelty pipes, and
673	2638		n. any pipe that has a tobacco bowl or chamber of less
674	2639		than one-half (1/2) inch in diameter in which there is
675	2640		any detectable residue of any controlled dangerous
676	2641		substance as defined in this section or any other
677	2642		substances not legal for possession or use;
678		-
679	2643		provided, however, the term "dr ug paraphernalia" shall not include
680	2644		separation gins intended for use in preparing tea or spice, clamps
681	2645		used for constructing electrical equipme nt, water pipes designed for
682	2646		ornamentation in which no detectable amount of an illegal su bstance
683	2647		is found or pipes designed and used solely for smoking tobacco,
684	2648		traditional pipes of an American Indian tribal religious ceremony,
685	2649		or antique pipes that are th irty (30) years of age or older;
686		-
687	2650		37. a. "Synthetic controlled substance" means a substanc e:
688		-
689	2651		(1) the chemical structure of which is substantially
690	2652		similar to the chemical structure of a controlled
691	2653		dangerous substance in Schedule I or II,
	2654	+
	2655	+	ENGR. H. B. NO. 3439 Page 24 1
	2656	+	2
	2657	+	3
	2658	+	4
	2659	+	5
	2660	+	6
	2661	+	7
	2662	+	8
	2663	+	9
	2664	+	10
	2665	+	11
	2666	+	12
	2667	+	13
	2668	+	14
	2669	+	15
	2670	+	16
	2671	+	17
	2672	+	18
	2673	+	19
	2674	+	20
	2675	+	21
	2676	+	22
	2677	+	23
	2678	+	24
692	2679
693	2680		(2) which has a stimulant, depressant, or
694	2681		hallucinogenic effect on the cent ral nervous
695	2682		system that is substan tially similar to or
696	2683		greater than the stimulant, depressant or
697	2684		hallucinogenic effect on the central nervous
698	2685		system of a controlled dangerous substance in
699	2686		Schedule I or II, or
700		-
701	2687		(3) with respect to a particular person, which such
702	2688		person represents or intends to have a stimulant,
703	2689		depressant, or hallucinogenic effect on the
704	2690		central nervous system that is substantially
705	2691		similar to or greater than the stimulant,
706	2692		depressant, or hallucinogenic effect on the
707	2693		central nervous system of a controlled dangerous
708	2694		substance in Schedule I or II.
709		-
710	2695		b. The designation of gamma butyrolactone or any other
711	2696		chemical as a precursor, pursuant to Section 2-322 of
712	2697		this title, does not preclude a findin g pursuant to
713	2698		subparagraph a of this paragraph that the chemical is
714	2699		a synthetic controlle d substance.
715		-
716		-	c. "Synthetic controlled substance" does not include: ENR. H. B. NO. 3439 Page 17
717		-
	2700	+	c. "Synthetic controlled substance" does not include:
718	2701		(1) a controlled dangerous substance,
719		-
720	2702		(2) any substance for which there is an approved new
721	2703		drug application,
	2704	+
	2705	+	ENGR. H. B. NO. 3439 Page 25 1
	2706	+	2
	2707	+	3
	2708	+	4
	2709	+	5
	2710	+	6
	2711	+	7
	2712	+	8
	2713	+	9
	2714	+	10
	2715	+	11
	2716	+	12
	2717	+	13
	2718	+	14
	2719	+	15
	2720	+	16
	2721	+	17
	2722	+	18
	2723	+	19
	2724	+	20
	2725	+	21
	2726	+	22
	2727	+	23
	2728	+	24
722	2729
723	2730		(3) with respect to a particular person any
724	2731		substance, if an exemption is in eff ect for
725	2732		investigational use, for that person under the
726	2733		provisions of Section 505 of the Federal Food,
727	2734		Drug and Cosmetic Act, Title 21 of the United
728	2735		States Code, Section 355, to the extent conduct
729	2736		with respect to such subst ance is pursuant to
730	2737		such exemption, or
731		-
732	2738		(4) any substance to the extent not intended for
733	2739		human consumption before such an exemption takes
734	2740		effect with respect to that substance.
735		-
736	2741		d. Prima facie evidence t hat a substance containing
737	2742		salvia divinorum has been en hanced, concentrated or
738	2743		chemically or physically altered s hall give rise to a
739	2744		rebuttable presumption that the substance is a
740	2745		synthetic controlled substance;
741		-
742	2746		38. "Tetrahydrocannabinols" means all subst ances that have been
743	2747		chemically synthesized to emulate the tetrahydrocannabinols of
744	2748		marijuana, specifically including any tetrahydrocannabinols derived
745	2749		from industrial hemp;
746		-
747	2750		39. "Isomer" means the optical isomer, except as used in
748	2751		subsections C and F of S ection 2-204 of this title and paragraph 4
749	2752		of subsection A of Section 2-206 of this title. As used in
750	2753		subsections C and F of Section 2-204 of this title, "isomer" means
	2754	+
	2755	+	ENGR. H. B. NO. 3439 Page 26 1
	2756	+	2
	2757	+	3
	2758	+	4
	2759	+	5
	2760	+	6
	2761	+	7
	2762	+	8
	2763	+	9
	2764	+	10
	2765	+	11
	2766	+	12
	2767	+	13
	2768	+	14
	2769	+	15
	2770	+	16
	2771	+	17
	2772	+	18
	2773	+	19
	2774	+	20
	2775	+	21
	2776	+	22
	2777	+	23
	2778	+	24
	2779	+
751	2780		the optical, positional or geometric isomer. As used in paragraph 4
752	2781		of subsection A of Section 2-206 of this title, the term "isomer"
753	2782		means the optical or geometric isomer;
754		-
755	2783		40. "Hazardous materials " means materials, whether solid,
756	2784		liquid or gas, which are toxic to human, animal, aquatic or plant
757	2785		life, and the disposal of which materials i s controlled by state or
758	2786		federal guidelines;
759		-
760	2787		41. "Anhydrous ammonia" means any substance that exhibits
761		-	cryogenic evaporative behavior and tests positive for ammonia; ENR. H. B. NO. 3439 Page 18
762		-
	2788	+	cryogenic evaporative behavior and tests positive for ammonia;
763	2789		42. "Acute pain" means pain, whether resulting from disease,
764	2790		accidental or intentional t rauma or other cause, that the
765	2791		practitioner reasonably expects to last only a short perio d of time.
766	2792		"Acute pain" does not include chronic pain, pain being treated as
767	2793		part of cancer care, hospice or other end-of-life care, or pain
768	2794		being treated as part of palliative care;
769		-
770	2795		43. "Chronic pain" means pain that pe rsists beyond the usual
771	2796		course of an acute disease or heal ing of an injury. "Chronic pain"
772	2797		may or may not be associated with an acute or chronic pathologic
773	2798		process that causes continuous or intermitte nt pain over months or
774	2799		years;
775		-
776	2800		44. "Initial prescriptio n" means a prescription issued to a
777	2801		patient who:
	2802	+
	2803	+	ENGR. H. B. NO. 3439 Page 27 1
	2804	+	2
	2805	+	3
	2806	+	4
	2807	+	5
	2808	+	6
	2809	+	7
	2810	+	8
	2811	+	9
	2812	+	10
	2813	+	11
	2814	+	12
	2815	+	13
	2816	+	14
	2817	+	15
	2818	+	16
	2819	+	17
	2820	+	18
	2821	+	19
	2822	+	20
	2823	+	21
	2824	+	22
	2825	+	23
	2826	+	24
778	2827
779	2828		a. has never previously been issued a prescription for
780	2829		the drug or its pharmaceutical equivalent in the past
781	2830		year, or
782		-
783	2831		b. requires a prescription for the drug or its
784	2832		pharmaceutical equivalent due to a surgica l procedure
785	2833		or new acute event and has previously had a
786	2834		prescription for the drug or its pharmaceutical
787	2835		equivalent within the past year.
788		-
789	2836		When determining whether a patient was previously issued a
790	2837		prescription for a drug or its pharmaceutical equivalent, th e
791	2838		practitioner shall consult with the patient and review t he medical
792	2839		record and prescription monitoring information of the patient;
793		-
794	2840		45. "Patient-provider agreement" means a written contract or
795	2841		agreement that is executed between a practitioner and a patien t,
796	2842		prior to the commencement of tr eatment for chronic pain using an
797	2843		opioid drug as a means to:
798		-
799	2844		a. explain the possible risk of development of physical
800	2845		or psychological dependence in the patient and pre vent
801	2846		the possible development of addiction,
802		-
803	2847		b. document the understanding of both the pra ctitioner
804	2848		and the patient regarding the patient-provider
805	2849		agreement of the patient,
806		-	ENR. H. B. NO. 3439 Page 19
807	2850		c. establish the rights of the patient in association
808	2851		with treatment and the obligat ions of the patient in
	2852	+
	2853	+	ENGR. H. B. NO. 3439 Page 28 1
	2854	+	2
	2855	+	3
	2856	+	4
	2857	+	5
	2858	+	6
	2859	+	7
	2860	+	8
	2861	+	9
	2862	+	10
	2863	+	11
	2864	+	12
	2865	+	13
	2866	+	14
	2867	+	15
	2868	+	16
	2869	+	17
	2870	+	18
	2871	+	19
	2872	+	20
	2873	+	21
	2874	+	22
	2875	+	23
	2876	+	24
	2877	+
809	2878		relation to the responsible use, discontinuation of
810	2879		use, and storage of opioid drugs, incl uding any
811	2880		restrictions on the refill of prescriptions or the
812	2881		acceptance of opioid prescriptions from practitioners,
813		-
814	2882		d. identify the specific me dications and other modes of
815	2883		treatment, including physi cal therapy or exercise,
816	2884		relaxation or psychological couns eling, that are
817	2885		included as a part of the patient-provider agreement,
818		-
819	2886		e. specify the measures the practitioner may employ to
820	2887		monitor the compliance of the patient including, but
821	2888		not limited to, rand om specimen screens and pill
822	2889		counts, and
823		-
824	2890		f. delineate the process for terminating the agreement,
825	2891		including the consequences if the practitioner has
826	2892		reason to believe that the patient is not complying
827	2893		with the terms of the agreement. Compliance with the
828	2894		"consent items" shall constitute a v alid, informed
829	2895		consent for opioid therapy. The practitioner shall be
830	2896		held harmless from civil litigation for failure to
831	2897		treat pain if the event occurs because of nona dherence
832	2898		by the patient with any of the provisions of t he
833	2899		patient-provider agreement;
834		-
835	2900		46. "Serious illness" mean s a medical illness or physical
836	2901		injury or condition that substantially affects quality of life for
	2902	+
	2903	+	ENGR. H. B. NO. 3439 Page 29 1
	2904	+	2
	2905	+	3
	2906	+	4
	2907	+	5
	2908	+	6
	2909	+	7
	2910	+	8
	2911	+	9
	2912	+	10
	2913	+	11
	2914	+	12
	2915	+	13
	2916	+	14
	2917	+	15
	2918	+	16
	2919	+	17
	2920	+	18
	2921	+	19
	2922	+	20
	2923	+	21
	2924	+	22
	2925	+	23
	2926	+	24
	2927	+
837	2928		more than a short period of time. "Serious illness" includes, but
838	2929		is not limited to, Alzheimer's d isease or related dementias, lung
839	2930		disease, cancer, heart f ailure, renal failure, liver failure or
840	2931		chronic, unremitting or intractable pain such as neuropathic pain;
841	2932		and
842		-
843	2933		47. "Surgical procedure" means a procedure that is performed
844	2934		for the purpose of struct urally altering the human body by incision
845	2935		or destruction of tissues as part of the practice of medicine. This
846	2936		term includes the diagnostic or therapeutic treatment of conditions
847	2937		or disease processes by use of instruments such as lasers,
848	2938		ultrasound, ionizing, radiation, scalpels, probes o r needles that
849	2939		cause localized alteration or transportation of live human tissue by
850	2940		cutting, burning, vaporizing, freezing, suturing, probing or
851		-	manipulating by closed reduction for major dislocations or ~~ENR. H. B. NO. 3439 Page 20~~
	2941	+	manipulating by closed reduction for major dislocations or
852	2942		fractures, or otherwise altering by any mechanical, thermal, light-
853	2943		based, electromagnetic or chemical means.
854		-
855		-	SECTION 5. It being immediately necessary for the preservation
	2944	+	SECTION 10. It being immediately necessary for the preservation
856	2945		of the public peace, health or safety, an emergency is hereby
857	2946		declared to exist, by r eason whereof this act shall take effect and
858	2947		be in full force from and after its passage and approval.
859		-	ENR. H. B. NO. 3439 Page 21
860		-	Passed the House of Representatives the 10th day of May, 2022.
	2948	+
	2949	+
	2950	+	ENGR. H. B. NO. 3439 Page 30 1
	2951	+	2
	2952	+	3
	2953	+	4
	2954	+	5
	2955	+	6
	2956	+	7
	2957	+	8
	2958	+	9
	2959	+	10
	2960	+	11
	2961	+	12
	2962	+	13
	2963	+	14
	2964	+	15
	2965	+	16
	2966	+	17
	2967	+	18
	2968	+	19
	2969	+	20
	2970	+	21
	2971	+	22
	2972	+	23
	2973	+	24
	2974	+
	2975	+	Passed the House of Representatives the 21st day of March, 2022.
861	2976
862	2977
863	2978
864	2979
865	2980		Presiding Officer of the House
866	2981		of Representatives
867	2982
868		-	Passed the Senate the 19th day of April, 2022.
	2983	+
	2984	+	Passed the Senate the ___ day of __________, 2022.
869	2985
870	2986
871	2987
872	2988
873	2989		Presiding Officer of the Senate
874	2990
875	2991
876	2992
877		-	OFFICE OF THE GOVERNOR
878		-	Received by the Office of the Governor this ____________________
879		-	day of ___________________, 20_______, at _______ o'clock _______ M.
880		-	By: _________________________________
881		-	Approved by the Governor of the State of Oklahoma th is _________
882		-	day of ___________________, 20_______, at _______ o'clock _______ M.
883		-
884		-
885		-	_________________________________
886		-	Governor of the State of Oklahoma
887		-
888		-	OFFICE OF THE SECRETARY OF STATE
889		-	Received by the Office of the Secretary of State this __________
890		-	day of ___________________, 20_______, at _______ o'clock _______ M.
891		-	By: _________________________________